US20040152999A1 - Low power consumption implantable pressure sensor - Google Patents
Low power consumption implantable pressure sensor Download PDFInfo
- Publication number
- US20040152999A1 US20040152999A1 US10/761,005 US76100504A US2004152999A1 US 20040152999 A1 US20040152999 A1 US 20040152999A1 US 76100504 A US76100504 A US 76100504A US 2004152999 A1 US2004152999 A1 US 2004152999A1
- Authority
- US
- United States
- Prior art keywords
- current
- pressure transducer
- driving time
- pressure
- control unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/202—Assessing bladder functions, e.g. incontinence assessment
- A61B5/205—Determining bladder or urethral pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/202—Assessing bladder functions, e.g. incontinence assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
- A61B5/6874—Bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0209—Operational features of power management adapted for power saving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
Definitions
- the present invention relates generally to implantable medical devices, and specifically to implantable pressure sensors.
- U.S. Pat. No. 6,221,024 to Miesel which is also assigned to Medtronic, Inc. and is incorporated herein by reference, describes a method for sealing oil-filled pressure transducer modules for a chronically-implantable pressure sensor lead.
- the '024 patent states: “U.S. Pat. No. 4,023,562 describes a pressure transducer comprising a piezoresistive bridge of four, orthogonally disposed, semiconductor strain gauges formed interiorly on a single crystal silicon diaphragm area of a silicon base. A protective silicon cover is bonded to the base around the periphery of the diaphragm area to form a sealed, evacuated chamber.
- Deflection of the diaphragm due to ambient pressure changes is detected by the changes in resistance of the strain gauges. Because the change in resistance is so small, a high current is required to detect the voltage change due to the resistance change. The high current requirements render the piezoresistive bridge unsuitable for long term use with an implanted power source. High gain amplifiers that are subject to drift over time are also required to amplify the resistance-related voltage change.”
- U.S. Pat. No. 5,564,434 to Halperin et al. which is incorporated herein by reference, describes an endocardial lead for implantation in a heart chamber.
- the lead is able to sense pressure changes via capacitors, and transmit information responsive to the pressure changes to an internal or external medical device.
- U.S. Pat. No. 6,238,423 to Bardy which is incorporated herein by reference, describes apparatus for treating chronic constipation, which includes an implantable pressure sensor for sensing tension in a wall of the digestive system.
- Measurement of pressure in the vicinity of the bladder and lower abdominal region is an important element in devices and methods for treating and controlling urinary incontinence.
- U.S. Pat. No. 6,135,945 to Sultan which is incorporated herein by reference, describes apparatus for preventing urinary incontinence.
- the described apparatus includes an implanted pressure sensor for sensing intra-abdominal pressure.
- U.S. Pat. No. 4,571,749 to Fischell which is incorporated herein by reference, describes an artificial sphincter device whose pressure can vary in response to changes in abdominal or intravesical (bladder) pressure.
- U.S. Pat. No. 5,562,717 to Tippey et al. which is incorporated herein by reference, describes electrical stimulation treatment for incontinence and other neuromuscular disorders, and includes a pressure sensor for determining changes in pressure in the vaginal or anal muscles.
- PCT Patent Publication WO 00/19939 to Gross et al. entitled “Control of urge incontinence,” which is assigned to the assignee of the present patent application and incorporated herein by reference, describes a device for treatment of urinary urge incontinence comprising a system in which imminent involuntary urine flow is sensed, and appropriate nerves or muscles are stimulated to inhibit the flow.
- US Patent Publication WO 00/19940 to Gross et al. entitled, “Incontinence treatment device,” which is assigned to the assignee of the present patent application and incorporated herein by reference, describes a device for treating urinary stress incontinence comprising a system in which imminent involuntary urine flow is sensed, and nerves or muscles are stimulated to inhibit the flow.
- apparatus to achieve the above objects comprises at least one implantable pressure-sensing device coupled to a control unit.
- the sensing device is preferably implanted in a patient's body at a location chosen in accordance with the particular condition being treated or diagnostic procedure being performed.
- the sensing device comprises an element characterized by electrical resistance that varies as a function of the pressure imposed upon it, typically a piezoresistive element.
- the pressure measuring apparatus is preferably designed such that the piezoresistive element of the sensing device is integrated into a Wheatstone bridge electrical circuit as one of the four resistors (typically adapting techniques described in one or more of the references cited hereinabove and incorporated herein by reference).
- two or more of the resistors in the Wheatstone bridge include piezoresistive elements.
- the sensing device operates by receiving a designated driving signal from the control unit and, as a function of the pressure upon it, undergoing a change in resistance that causes a measurable variation in the voltage output of the Wheatstone bridge.
- the driving signal includes a series of relatively short duration, low duty cycle pulses.
- the actual time during which the apparatus consumes power by driving current through the Wheatstone bridge and taking measurements is significantly less than the total time of operation of the apparatus.
- a major shortcoming is high power consumption, which limits usable lifetime and imposes demanding requirements upon power supplies, such as batteries.
- MP35N or platinum/iridium (Pt/Ir), or, less commonly, alloys having iron in low quantities (e.g., moderately or significantly less than 60% iron by weight), as these materials have proven to be both safe and effective for many applications in the human body.
- a problem with using MP35N (or these other materials) for electrical leads is that it does not solder well to copper, which is a common conductor in electrical circuits.
- increasing iron content is associated with increased facility in soldering, but decreased biocompatibility.
- MP35N and Pt/Ir having essentially no iron, are particularly difficult to solder using standard techniques.
- MP35N wires are used to connect the control unit to a circuit in an implanted pressure sensor or other medical device.
- the problem of securely connecting the MP35N wire to the circuit board is overcome by using an intermediate conductor to couple MP35N wires to the circuit.
- a stainless steel cylinder is mechanically coupled to an MP35N wire, for example by crimping. The stainless steel cylinder is then soldered to the circuit board.
- the cylinder comprises other biocompatible conductors, suitable for being mechanically coupled to the MP35N wire and for soldering to the circuit board.
- the solder used to couple the MP35N wire and the circuit board comprises indium, preferably a high percentage of indium, as the inventors have found that this facilitates good electrical coupling of the MP35N wire and the circuit board, even without the use of stainless steel cylinders.
- the electrical circuit in the pressure measuring apparatus and the connections to the MP35N wires are secured inside a hollow stainless steel tube or other casing comprising a sensing hole through which pressure changes can be measured.
- the tube is filed with a generally-incompressible biocompatible substance that efficiently conveys pressure changes, such as a silicon gel.
- the tube has one or more gel-transport holes through which the gel can be added, while excess gel is forced through the sensing hole and/or the other gel-transport holes, such that all air bubbles are forced out of the tube.
- the gel-transport holes may include the sensing hole. It is important to remove any air bubbles in order to obtain accurate pressure measurements, as air bubbles in the gel reduce the sensitivity of the pressure sensor.
- the senor is coated with a protective substance, such as parylene, to protect it from external moisture.
- a protective substance such as parylene
- the stainless steel tube is further encased in a flexible tube, such as one made of silicone, which is able to convey pressure fluctuations through the sensing hole to the pressure sensor, while maintaining the integrity of the sensor and the gel.
- pressure-measuring apparatus including:
- a pressure transducer which is adapted to be placed in a patient, the pressure transducer having a characteristic mechanical response bandwidth f, and a corresponding mechanical response period p equal to 1/f;
- a control unit which is adapted to actuate the battery to drive current through the pressure transducer for a current-driving time period less than 0.5 p, and to sense an electrical characteristic of the pressure transducer during the current-driving time period.
- the pressure transducer is adapted to be implanted in the patient.
- the pressure transducer is adapted to be incorporated in a catheter.
- the pressure transducer is adapted to measure an abdominal pressure of the patient, a pressure of a urinary bladder of the patient, a cardiac pressure of the patient, or a blood pressure of the patient.
- the pressure transducer preferably includes a piezoresistive pressure transducer, incorporated in a Wheatstone bridge circuit.
- control unit is adapted to set the current-driving time period to be less than 1000 microseconds.
- the control unit is typically adapted to designate an initial portion of the current-driving time period as a pressure-transducer stabilization period, during which the control unit withholds from sensing the characteristic.
- control unit may be adapted such that, in sensing the electrical characteristic, the control unit senses a current passing through the pressure transducer and/or a voltage drop across two points of the pressure transducer.
- the control unit is preferably adapted to sense the electrical characteristic substantially only during the current-driving time period.
- control unit is adapted to actuate the battery to expend less than 5 microjoules in driving the current through the pressure transducer.
- control unit is preferably adapted to actuate the battery to drive the current directly into the pressure transducer, substantially without charging a capacitor located at a placement site of the pressure transducer.
- control unit is preferably adapted to actuate the battery to drive the current directly into the pressure transducer, substantially without charging a capacitor located at a placement site of the pressure transducer having capacitance greater than 0.1 nF.
- control unit is adapted to actuate the battery to drive current into the pressure transducer during a plurality of current-driving time periods, each less than 0.5 p, and to sense respective electrical characteristics of the pressure transducer during each of the current-driving time periods.
- the battery is preferably adapted to drive the current directly into the pressure transducer, substantially without charging a capacitor located at a placement site of the pressure transducer during each of the current-driving time periods.
- control unit is adapted to actuate the battery to drive current through the pressure transducer during a plurality of current-driving time periods, each less than 0.5 p.
- a duty cycle of the control unit (defined by a length of one of the current-driving time periods divided by a time between the initiation of two successive current-driving time periods) is preferably less than 0.3%, or even less than 0.03%.
- the apparatus includes a signal processor, adapted to be placed in the patient at a common placement site with the pressure transducer and to process the sensed electrical characteristic.
- the signal processor may include an amplifier, adapted to amplify the sensed electrical characteristic.
- the signal processor includes a microprocessor.
- the apparatus preferably includes:
- a first set of wires adapted to couple the control unit to the microprocessor
- a second set of wires adapted to couple the microprocessor to the pressure transducer
- control unit may be adapted to set the current-driving time period to be less than 0.1 p, less than 0.02 p, or even less than 0.004 p.
- control unit is adapted: (a) to actuate the battery to drive current through the pressure transducer during a plurality of current-driving time periods, each less than 0.5 p, (b) to sense respective electrical characteristics of the pressure transducer during each of the current-driving time periods, and (c) to space the current-driving time periods by at least ten milliseconds.
- control unit is adapted to space the current-driving time periods by at least one second, by at least one minute, or even by at least one hour.
- pressure-measuring apparatus including:
- a pressure transducer which is adapted to be placed at a pressure-sensing site in a patient, the pressure transducer having a characteristic mechanical response bandwidth f, and a corresponding mechanical response period p equal to 1/f;
- a control unit adapted to be placed at a control-unit site at least 3 cm from the pressure-sensing site, to drive current through the pressure transducer for a current-driving time period less than 0.5 p, and to sense an electrical characteristic of the pressure transducer during the current-driving time period.
- control unit is adapted to be placed at a control-unit site which is at least 5 cm from the pressure-sensing site.
- pressure-measuring apparatus including:
- a pressure transducer which is adapted to be placed in a patient
- a control unit which is adapted to actuate the battery to drive current through the pressure transducer for a current-driving time period less than 1000 microseconds, and to sense an electrical characteristic of the pressure transducer during the current-driving time period.
- control unit is adapted to set the current-driving time period to be less than 250 microseconds, less than 50 microseconds, less than 10 microseconds, or even less than 2 microseconds.
- pressure-measuring apparatus including:
- a pressure transducer which is adapted to be placed at a pressure-sensing site in a patient
- a control unit adapted to be placed at a control-unit site at least 3 cm from the pressure-sensing site, to drive current through the pressure transducer for a current-driving time period less than 1000 microseconds, and to sense an electrical characteristic of the pressure transducer during the current-driving time period.
- apparatus which is adapted to be placed in a patient, including:
- circuitry which is adapted to be placed in a patient
- an electrically-conductive connector which is crimped to the lead wire so as to be electrically coupled thereto, and which is soldered to the circuitry.
- the lead wire includes an MP35N lead wire, a platinum/iridium lead wire, or a wire including 1-60% iron by weight.
- the connector includes a hollow tube, wherein a portion of the lead wire is disposed within the hollow tube, and wherein the hollow tube is crimped to the portion of the lead wire.
- the connector includes stainless steel.
- the circuitry is adapted to be implanted in the patient.
- the circuitry is adapted to be incorporated in a catheter.
- the circuitry includes a sensor, such as a pressure sensor, a temperature sensor, and/or a chemical sensor.
- the sensor includes an electrode, adapted to sense electrical activity in tissue of the patient where the apparatus is placed.
- the sensor includes a flow sensor, adapted to sense a flow of blood in a vicinity of the apparatus.
- the circuitry includes an active element, such as a stimulating electrode, a light source adapted to facilitate photodynamic therapy, an electroactive polymer, and/or a mechanical actuator.
- an active element such as a stimulating electrode, a light source adapted to facilitate photodynamic therapy, an electroactive polymer, and/or a mechanical actuator.
- apparatus which is adapted to be placed in a patient, including:
- circuitry which is adapted to be placed in the patient
- a lead wire selected from the group consisting of: an MP35N lead wire, a platinum/iridium lead wire, and lead wire including 1-60% iron by weight; and
- solder including at least 20% indium by weight, for electrically coupling the lead wire to the circuitry.
- the solder includes at least 50% indium.
- apparatus which is adapted to be placed in a patient, including:
- a hollow casing one or more holes being disposed in a wall thereof, inside which casing the electronic device and the gel are disposed, the casing being configured to facilitate flow of some of the gel out of the one or more holes when the casing is being filled with the gel.
- the apparatus includes including a flexible covering, adapted to fit around at least a portion of the hollow casing.
- the flexible covering includes a flexible silicon covering.
- the hollow casing includes a rigid hollow casing, e.g., a hollow stainless steel casing.
- the circuitry includes a pressure sensor, disposed within the casing such that pressure changes at a patient site where the apparatus is placed are conveyed to the pressure transducer via the gel.
- a sensing hole is disposed in the hollow casing, and a substantially non-metallic flexible covering is disposed outside the casing, so as to cover the sensing hole and to convey pressure changes at the patient site through the sensing hole to the gel.
- the diameter of the sensing hole is typically less than 2 mm.
- FIG. 1 is a schematic diagram of an implanted pressure measuring system, in accordance with a preferred embodiment of the present invention
- FIGS. 2A and 2B are illustrative examples of power signals driven into a sensing device by a control unit, in accordance with a preferred embodiment of the present invention.
- FIGS. 3A and 3B are schematic diagrams of a connection system between MP35N wires and a chip, in accordance with a preferred embodiment of the present invention.
- FIGS. 4A and 4B are schematic diagrams of another connection system between MP35N wires and a chip, in accordance with a preferred embodiment of the present invention.
- FIG. 5 is a sectional schematic diagram of an implantable pressure transducer, in accordance with a preferred embodiment of the present invention.
- FIG. 1 is a schematic diagram of an implanted pressure measurement system 100 , in accordance with a preferred embodiment of the present invention.
- the example shown is a system for measuring pressure in the urinary bladder 110 of a patient, although it is to be appreciated that system 100 could be implanted to measure pressure at any of a number of appropriate sites in the patient's body, e.g., at a cardiac site.
- System 100 typically includes an implantable or external control unit 102 including a signal generator 104 , a signal analysis unit 106 , and an implantable pressure sensor 114 .
- pressure sensor 114 includes a piezoresistive element R X which is electrically connected as one element in a Wheatstone bridge circuit arrangement. For some applications, two or more piezoresistive elements are incorporated into corresponding respective positions in a Wheatstone bridge.
- a power source 118 is preferably included within control unit 102 , and is coupled to provide energy to signal generator 104 and signal analysis unit 106 from rechargeable or non-rechargeable batteries or another replaceable or renewable source of power.
- Signal generator 104 sends pulsed signals to pressure sensor 114 .
- Pressure sensor 114 which includes piezoresistive element R X whose resistance is a function of the pressure imposed upon it, returns a voltage signal (measured between points B and C in the Wheatstone bridge) to control unit 102 commensurate with the value of resistance R X at the instant of measurement.
- This voltage signal is amplified and input to signal analysis unit 106 where it is interpreted as a pressure measurement.
- Wheatstone bridges used in prior art implantable medical devices require a relatively large amount of power to operate, as it is the practice to apply power generally continuously, and to sample intermittently, in order to obtain a signal.
- continuous monitoring with a Wheatstone bridge is not efficient in an implanted device, which necessarily has a limited power supply.
- the positive aspects of a Wheatstone bridge namely that it is simple, inexpensive, and sensitive to small changes, have therefore not been able to be efficiently utilized using the continuous-operation modes associated therewith in the prior art.
- signals are preferably driven from signal generator 104 to pressure sensor 114 in the form of intermittent pulses.
- the delay between successive pressure readings is preferably determined based on the particular application. For example, a single daily blood pressure measurement may be sufficient for some applications, such that the total power requirement is negligible. Cardiac pressure measurements, intended for example to track heart failure, may be performed at 5 Hz. A system for identifying the onset of stress incontinence may sample at 30 Hz. Further, because action potential propagation is associated with mechanical deformations of axons, pressure changes responsive to these deformations may be sampled at 2000 Hz.
- these embodiments of the present invention are significantly more efficient than piezoresistive pressure-sampling methods known in the art, because these embodiments commonly perform sampling during intermittent short time periods whose reciprocals correspond to sampling rates 2, 100, or even 1000 times higher than the characteristic mechanical response bandwidth of the piezoresistive pressure sensors
- a sampling pseudo-frequency of 100 kHz is obtained (i.e., the reciprocal of 10 ⁇ sec), far above a 1 kHz bandwidth characteristic of many piezoresistive pressure sensors which are ready for implantation.
- the term “characteristic mechanical response bandwidth” refers to the bandwidth in a fully-assembled pressure-sensing device, and not to the theoretical bandwidth attainable, for example, by a piezoresistive circuit unencumbered by gel or supporting structure.
- a piezoresistive circuit may have a theoretical bandwidth of 10 kHz, once it is incorporated into a fully-assembled pressure-sensing device, the characteristic mechanical response bandwidth of the device would be closer to 1 kHz.
- FIGS. 2A and 2B show an illustrative example of a preferred pulse waveform to facilitate measuring pressure in the bladder of a patient, in accordance with a preferred embodiment of the present invention.
- signal generator 104 sends pulses to pressure sensor 114 at a driving rate of 32 Hz (FIG. 2A), although it is to be understood that other driving rates (e.g., between 10 ⁇ Hz and 3 kHz) may also be used, as appropriate for a particular application.
- a typical stabilization period for a preferred piezoresistive device upon which pressure is imposed is approximately 1 ⁇ sec.
- a suitable definition of “stabilization period” for most applications is the time from the first application of current to sensor 114 until the time when the output of the sensor reaches 90% of maximum.
- a constant-pressure calibration period of sensor 114 is provided, in which samples are taken at various times after the first application of current to the sensor (e.g., every 100 nanoseconds), until the samples reach a steady-state value.
- a calibration function C(t) is thus determined, to facilitate corrections to be made to data which are sampled during the stabilization period during regular operation of sensor 114 .
- this method allows the total time during which current is driven through pressure sensor 114 to be very short, e.g., only several tens or hundreds of nanoseconds.
- FIG. 2B is a magnified schematic of a typical pulse shown in FIG. 2A with a sampling time of 10 ⁇ sec.
- no data are typically recorded during the stabilization period.
- the total power consumption in this example is reduced by a factor of 1/0.000352 or almost 3000.
- the issue of power consumption a major consideration in design of prior art active devices implanted in patients, is significantly reduced in preferred embodiments of the present invention.
- a low power consumption pressure sensor is described in a preferred embodiment utilizing a piezoresistive element and a Wheatstone bridge arrangement. This is considered as illustrative only of certain aspects of the invention. Since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the invention to the exact construction and operation shown and described. Accordingly, all suitable modifications and equivalents in materials and circuitry that enable a change in resistance or another parameter to be utilized to measure changes in pressure in an implanted device utilizing a low measurement duty cycle may be considered to fall within the scope of the invention. Preferred duty cycles are typically, but not necessarily, below 0.3% or even 0.03%.
- connection system 120 for use, for example, in the implantable pressure sensor described hereinabove with reference to FIG. 1, in accordance with a preferred embodiment of the present invention. It is to be understood, however, that the apparatus and methods described with reference to FIGS. 3A and 3B could alternatively or additionally be applied with a range of circuitry, such as, for example, a signal processor such as a microprocessor, sensors such as pressure sensors other than those described herein, temperature sensors, chemical sensors (e.g., glucose sensors), flow sensors, or sensing electrodes. Further alternatively or additionally, connection system 120 may be used in combination with active elements, such as, by way of illustration and not limitation, actuators, stimulating electrodes, electroactive polymers, or light sources for photodynamic therapy.
- active elements such as, by way of illustration and not limitation, actuators, stimulating electrodes, electroactive polymers, or light sources for photodynamic therapy.
- connection system 120 provides means for connecting control unit 102 to pressure sensor 114 (FIG. 1) via MP35N wires 128 .
- MP35N is a preferred alloy for implantable medical devices.
- the pressure sensing means is included in a chip 124 , which is fixed to a circuit board 122 including four copper conductive elements 126 . Conductive elements 126 are, in turn, coupled to four or more wires 134 which function to transmit signals to and from chip 124 .
- Coupling MP35N wires 128 to conductive elements 126 is optimally not accomplished by direct soldering, as MP35N wires do not solder satisfactorily to copper.
- a stainless steel cylinder 130 is mechanically coupled to the end of each MP35N wire, for example via crimping (FIG. 3B), so as to achieve good electrical contact therewith, and the cylinder is subsequently coupled to conductive elements 126 by a solder joint 132 , using techniques known in the art. It is noted that stainless steel can be satisfactorily soldered to copper and is also suitable for chronic implantation in the human body, using known procedures. To obtain improved electrical conduction, cylinders 130 are preferably coated with gold prior to soldering.
- cylinders 130 are treated with phosphoric acid to improve electrical conduction.
- Wires 128 are also preferably coated with a substance such as Teflon using standard methods so as to prevent short circuits between the wires. Additionally, the portion of wires 128 between the circuit board and the control unit are preferably wound together into a coil and enclosed in a flexible tube 136 for further protection and ease of handling during implantation.
- FIG. 4A is a schematic drawing of a connection system 140 for use, for example, in the implantable pressure sensor described hereinabove with reference to FIG. 1, in accordance with a preferred embodiment of the present invention.
- connection system 140 may also be facilitated through the use of connection system 140 .
- connection system 140 including a chip 144 including pressure sensor 114 , is preferably soldered with indium solder joints 148 to conductive elements 146 of a circuit board 142 .
- Chip 144 is preferably electrically coupled to conductive elements 146 by small connecting wires 150 .
- solder joints 148 include at least 10% indium by weight (typically 50-100% indium).
- FIG. 4B is a schematic drawing of a connection system 240 , in accordance with a preferred embodiment of the present invention.
- System 240 is generally similar to system 140 , described hereinabove with reference to FIG. 4A, except for differences as noted.
- Circuit board 142 comprises a signal processor 202 , which, in turn, comprises a microprocessor 204 and an amplifier 200 .
- Amplifier 200 preferably amplifies a voltage drop v(t) generated during operation of chip 144 (e.g., responsive to pressure changes applied to a piezoresistive element), and microprocessor 204 digitizes the amplified signal.
- the number of wires 128 coupling control unit 102 to circuit board 142 can by these means be reduced, with no loss in functionality.
- only two wires 128 couple control unit 102 to microprocessor 204 , and these wires carry power to the microprocessor, in order to facilitate the microprocessor's operations.
- the microprocessor may be coupled to the control unit by the two wires 128 , and to a pressure sensor 114 in chip 144 by four conductors 147 . Results of the pressure sensing are then preferably conveyed by microprocessor 204 to the control unit by applying a modulation signal onto the two wires 128 that carry power to the microprocessor.
- circuit board 142 includes a microprocessor, especially in combination with an amplifier, the noise which might otherwise corrupt a low-amplitude analog signal to some extent during its propagation to control unit 102 is substantially reduced.
- connection system 240 may be incorporated into catheter apparatus (not shown), or other non-implanted sensing or active devices, so as to benefit from the reduced signal noise and wire-count which are attainable by performing processing at the actual sensed or treated site.
- standard techniques perform substantially all of their processing remote from the sensed or treated site.
- a catheter has a pressure sensor, microprocessor, and amplifier, at the distal end thereof, constructed using techniques described herein, and conveys digitized pressure readings to a control unit external to the patient's body, preferably via only two leads coupling the microprocessor and the control unit.
- FIG. 5 is a sectional schematic drawing of an implantable device 160 , in accordance with a preferred embodiment of the present invention.
- Device 160 includes chip 124 , which preferably contains a pressure-sensing element, and connection system 120 to transmit pressure data to a control unit (not shown), as described hereinabove with reference to FIGS. 3A and 3B.
- Applications other than pressure sensing, such as those described with reference to FIGS. 3A and 3B, may be alternatively or additionally incorporated into device 160 .
- device 160 may include an implantable temperature or chemical sensor, or an implantable electrode.
- a stainless steel cylinder 166 is used to protect the chip and the connection system during implantation in the body, and, subsequently, from the physiological environment inside the patient's body.
- Cylinder 166 provides a rigid surface to which to fasten circuit board 122 , thus providing a stable base for chip 124 , which includes pressure-sensing apparatus.
- a UV-hardened glue 172 is used to increase the mechanical strength of connections in the device.
- a pressure-sensing hole 168 is present in cylinder 166 , typically adjacent to the pressure-sensing apparatus of chip 124 , so that the pressure of the surrounding tissue can be sensed. Hole 168 may be, for example, 1.8 mm in diameter.
- Two fill holes 170 in cylinder 166 are used to fill cylinder 166 with a pressure transducing substance, preferably a silicon gel 174 .
- a pressure transducing substance preferably a silicon gel 174 .
- a plurality of holes are used so that as gel 174 is fed in one hole 170 , any trapped air or excess gel can exit the other hole 170 or hole 168 . It is preferred to remove all air bubbles from cylinder 166 in order to obtain a uniform medium in the cylinder and thereby facilitate the accurate measurement of the pressure external to cylinder 166 .
- Electrical components inside cylinder 166 are protected from moisture by a thin coating such as parylene, typically several microns deep.
- cylinder 166 is preferably encased in a flexible covering such as a flexible tube 162 , capable of conveying body pressures to the pressure sensing apparatus inside cylinder 166 .
- tube 162 includes silicon, and a silicon glue cap 164 is placed at one end of tube 166 following the placement of the gel in cylinder 166 .
- the flexible covering is preferably largely non-metallic.
- the apparatus or methods described herein for measuring physiological pressures, for other sensing tasks, or for applying currents or for other active tasks are used to facilitate corresponding operations, such as those described in the above-cited US patent application, entitled, “Pelvic disorder treatment device,” filed Nov. 29, 2001, which shares common inventorship with the inventorship of the present patent application, is assigned to the assignee of the present patent application, and is incorporated herein by reference.
Abstract
Description
- This application is a continuation-in-part of a US patent application, entitled, “Pelvic disorder treatment device,” filed Nov. 29, 2001, which shares common inventorship with the inventorship of the present patent application, is assigned to the assignee of the present patent application, and is incorporated herein by reference.
- The present invention relates generally to implantable medical devices, and specifically to implantable pressure sensors.
- A significant effort has been underway for many years to develop implantable medical devices for direct measurement of physiological parameters of a patient for both temporary and chronic use. Some prior art devices cannot be implanted in the body due to their undesirably large size, limited life span, or high power consumption Challenges exist, for example, in developing efficient commercial pressure transducers, capable of being used in the body of a patient for direct measurement of physiologic pressures such as urinary bladder, abdominal, respiratory, cardiac, venous, arterial, amniotic, and cerebrospinal fluid pressures. For example, suitable implantable cardiac pressure sensors which have very low power consumption for tracking the condition of a heart failure patient are not available.
- U.S. Pat. No. 6,248,083 to Smith et al., U.S. Pat. No. 5,969,591 to Fung, U.S. Pat. No. 5,566,680 to Urion et al., U.S. Pat. No. 5,522,266 to Nicholson et al., U.S. Pat. No. 5,184,619 to Austin, U.S. Pat. No. 4,873,986 to Wallace, and U.S. Pat. No. 4,825,876 to Beard, which are incorporated herein by reference, describe the use of piezoresistive elements to facilitate pressure measurements for medical applications.
- U.S. Pat. No. 4,407,296 to Anderson, which is incorporated herein by reference, describes a hermetically-sealed piezoresistive pressure transducer for implantation in the body.
- U.S. Pat. No. 4,846,191 to Brockeway et al., which is incorporated herein by reference, describes an implantable device for chronic measurement of internal body pressures. The device may include a piezoresistive element.
- U.S. Pat. No. 4,023,562 to Hynecek et al., which is incorporated herein by reference, describes an implantable piezoresistive pressure transducer for monitoring internal fluid or pneumatic pressures within the body.
- U.S. Pat. No. 4,432,372 to Monroe, which is assigned to Medtronic, Inc. and is incorporated herein by reference, describes apparatus for multiplexing the power and signal leads of an implantable piezoelectric pressure transducer. A device built according to the description in the Monroe patent charges a capacitor located at the pressure transducer site, and, subsequently, allows the capacitor to discharge through a Wheatstone bridge. The capacitor is a fundamental component of this device, as it permits the time-sharing of power functions and sensing functions into only two wires. Although not stated in the Monroe patent, it is known that repeated charging and discharging of capacitors is often associated with significant heat dissipation, and, therefore, increased energy consumption.
- U.S. Pat. No. 6,221,024 to Miesel, which is also assigned to Medtronic, Inc. and is incorporated herein by reference, describes a method for sealing oil-filled pressure transducer modules for a chronically-implantable pressure sensor lead. The '024 patent states: “U.S. Pat. No. 4,023,562 describes a pressure transducer comprising a piezoresistive bridge of four, orthogonally disposed, semiconductor strain gauges formed interiorly on a single crystal silicon diaphragm area of a silicon base. A protective silicon cover is bonded to the base around the periphery of the diaphragm area to form a sealed, evacuated chamber. Deflection of the diaphragm due to ambient pressure changes is detected by the changes in resistance of the strain gauges. Because the change in resistance is so small, a high current is required to detect the voltage change due to the resistance change. The high current requirements render the piezoresistive bridge unsuitable for long term use with an implanted power source. High gain amplifiers that are subject to drift over time are also required to amplify the resistance-related voltage change.”
- U.S. Pat. No. 5,564,434 to Halperin et al., which is incorporated herein by reference, describes an endocardial lead for implantation in a heart chamber. The lead is able to sense pressure changes via capacitors, and transmit information responsive to the pressure changes to an internal or external medical device.
- U.S. Pat. No. 5,330,505 to Cohen, which is incorporated herein by reference, describes implantable sensors for sensing a variety of cardiac physiologic signals.
- U.S. Pat. No. 6,238,423 to Bardy, which is incorporated herein by reference, describes apparatus for treating chronic constipation, which includes an implantable pressure sensor for sensing tension in a wall of the digestive system.
- U.S. Pat. No. 6,240,316 to Richmond et al., which is incorporated herein by reference, describes the use of implanted pressure sensors in apparatus for treating sleep apnea.
- Measurement of pressure in the vicinity of the bladder and lower abdominal region is an important element in devices and methods for treating and controlling urinary incontinence. U.S. Pat. No. 6,135,945 to Sultan, which is incorporated herein by reference, describes apparatus for preventing urinary incontinence. The described apparatus includes an implanted pressure sensor for sensing intra-abdominal pressure. U.S. Pat. No. 4,571,749 to Fischell, which is incorporated herein by reference, describes an artificial sphincter device whose pressure can vary in response to changes in abdominal or intravesical (bladder) pressure. U.S. Pat. No. 5,562,717 to Tippey et al., which is incorporated herein by reference, describes electrical stimulation treatment for incontinence and other neuromuscular disorders, and includes a pressure sensor for determining changes in pressure in the vaginal or anal muscles.
- PCT Patent Publication WO 00/19939 to Gross et al., entitled “Control of urge incontinence,” which is assigned to the assignee of the present patent application and incorporated herein by reference, describes a device for treatment of urinary urge incontinence comprising a system in which imminent involuntary urine flow is sensed, and appropriate nerves or muscles are stimulated to inhibit the flow.
- US Patent Publication WO 00/19940 to Gross et al., entitled, “Incontinence treatment device,” which is assigned to the assignee of the present patent application and incorporated herein by reference, describes a device for treating urinary stress incontinence comprising a system in which imminent involuntary urine flow is sensed, and nerves or muscles are stimulated to inhibit the flow.
- In general, for implanted pressure sensors, issues of size, durability, accuracy and, particularly, power consumption are major considerations that must be addressed in order to ensure that the goals of the application are achieved.
- It is an object of some aspects of the present invention to provide improved apparatus and methods for reducing power consumption in a pressure sensor implanted in the body of a patient.
- It is also an object of some aspects of the present invention to provide improved methods and apparatus for reducing heat dissipation in a pressure sensor implanted in the body of a patient.
- It is a further object of some aspects of the present invention to provide improved apparatus and methods for increasing the useful lifetime of an implantable device.
- It is yet a further object of some aspects of the present invention to provide improved methods for enabling the coupling of MP35N wires and other materials in lead wires to circuitry in an implantable device.
- It is still a further object of some aspects of the present invention to provide less-complicated methods and apparatus for producing an implantable device.
- It is also an object of some aspects of the present invention to provide improved methods and apparatus for producing a low cost implantable device.
- In preferred embodiments of the present invention, apparatus to achieve the above objects comprises at least one implantable pressure-sensing device coupled to a control unit. The sensing device is preferably implanted in a patient's body at a location chosen in accordance with the particular condition being treated or diagnostic procedure being performed. Preferably, the sensing device comprises an element characterized by electrical resistance that varies as a function of the pressure imposed upon it, typically a piezoresistive element. The pressure measuring apparatus is preferably designed such that the piezoresistive element of the sensing device is integrated into a Wheatstone bridge electrical circuit as one of the four resistors (typically adapting techniques described in one or more of the references cited hereinabove and incorporated herein by reference). Alternatively, two or more of the resistors in the Wheatstone bridge include piezoresistive elements. The sensing device operates by receiving a designated driving signal from the control unit and, as a function of the pressure upon it, undergoing a change in resistance that causes a measurable variation in the voltage output of the Wheatstone bridge. The driving signal includes a series of relatively short duration, low duty cycle pulses.
- Consequently, in preferred embodiments of the present invention, the actual time during which the apparatus consumes power by driving current through the Wheatstone bridge and taking measurements is significantly less than the total time of operation of the apparatus. In prior art implantable piezoresistive pressure sensors, by contrast, a major shortcoming is high power consumption, which limits usable lifetime and imposes demanding requirements upon power supplies, such as batteries.
- Electrical leads for implantable medical devices are often composed of MP35N or platinum/iridium (Pt/Ir), or, less commonly, alloys having iron in low quantities (e.g., moderately or significantly less than 60% iron by weight), as these materials have proven to be both safe and effective for many applications in the human body. A problem with using MP35N (or these other materials) for electrical leads is that it does not solder well to copper, which is a common conductor in electrical circuits. In particular, increasing iron content is associated with increased facility in soldering, but decreased biocompatibility. MP35N and Pt/Ir, having essentially no iron, are particularly difficult to solder using standard techniques. The following solution, and that elaborated more completely in the Detailed Description of Preferred Embodiments, while described with respect to MP35N by way of illustration, applies as well to platinum/iridium and other alloys having low iron content (e.g., 1-60% iron, 1-40% iron, or 1-20% iron). Additionally, it applies to DFT wire (Fort Wayne Metals, Fort Wayne, Ind.) and other similar types of lead wires, in which a highly-conductive core is surrounded by a less conductive, more biocompatible outer surface. For example, the techniques described herein may be applied to a lead wire having MP35N over a silver core.
- In preferred embodiments of the present invention, MP35N wires are used to connect the control unit to a circuit in an implanted pressure sensor or other medical device. The problem of securely connecting the MP35N wire to the circuit board is overcome by using an intermediate conductor to couple MP35N wires to the circuit. In some preferred embodiments, a stainless steel cylinder is mechanically coupled to an MP35N wire, for example by crimping. The stainless steel cylinder is then soldered to the circuit board. In other preferred embodiments, the cylinder comprises other biocompatible conductors, suitable for being mechanically coupled to the MP35N wire and for soldering to the circuit board. In further preferred embodiments of the present invention, the solder used to couple the MP35N wire and the circuit board comprises indium, preferably a high percentage of indium, as the inventors have found that this facilitates good electrical coupling of the MP35N wire and the circuit board, even without the use of stainless steel cylinders.
- In order for the electrical circuit comprising the pressure measuring apparatus to function properly inside the human body, it must be protected from the generally electronics-incompatible environment at the implant location. Additionally, the device must be robust enough to survive the implant procedure. Thus, in preferred embodiments of the present invention, the electrical circuit in the pressure measuring apparatus and the connections to the MP35N wires are secured inside a hollow stainless steel tube or other casing comprising a sensing hole through which pressure changes can be measured. Preferably, the tube is filed with a generally-incompressible biocompatible substance that efficiently conveys pressure changes, such as a silicon gel. The tube has one or more gel-transport holes through which the gel can be added, while excess gel is forced through the sensing hole and/or the other gel-transport holes, such that all air bubbles are forced out of the tube. Optionally, the gel-transport holes may include the sensing hole. It is important to remove any air bubbles in order to obtain accurate pressure measurements, as air bubbles in the gel reduce the sensitivity of the pressure sensor.
- Preferably, the sensor is coated with a protective substance, such as parylene, to protect it from external moisture. In a preferred embodiment, the stainless steel tube is further encased in a flexible tube, such as one made of silicone, which is able to convey pressure fluctuations through the sensing hole to the pressure sensor, while maintaining the integrity of the sensor and the gel.
- There is therefore provided, in accordance with a preferred embodiment of the present invention, pressure-measuring apparatus, including:
- a battery;
- a pressure transducer, which is adapted to be placed in a patient, the pressure transducer having a characteristic mechanical response bandwidth f, and a corresponding mechanical response period p equal to 1/f; and
- a control unit, which is adapted to actuate the battery to drive current through the pressure transducer for a current-driving time period less than 0.5 p, and to sense an electrical characteristic of the pressure transducer during the current-driving time period.
- Typically, the pressure transducer is adapted to be implanted in the patient. Alternatively, the pressure transducer is adapted to be incorporated in a catheter.
- For some applications, the pressure transducer is adapted to measure an abdominal pressure of the patient, a pressure of a urinary bladder of the patient, a cardiac pressure of the patient, or a blood pressure of the patient.
- The pressure transducer preferably includes a piezoresistive pressure transducer, incorporated in a Wheatstone bridge circuit.
- In a preferred embodiment, the control unit is adapted to set the current-driving time period to be less than 1000 microseconds. The control unit is typically adapted to designate an initial portion of the current-driving time period as a pressure-transducer stabilization period, during which the control unit withholds from sensing the characteristic.
- As appropriate, the control unit may be adapted such that, in sensing the electrical characteristic, the control unit senses a current passing through the pressure transducer and/or a voltage drop across two points of the pressure transducer. The control unit is preferably adapted to sense the electrical characteristic substantially only during the current-driving time period.
- Preferably, the control unit is adapted to actuate the battery to expend less than 5 microjoules in driving the current through the pressure transducer. Moreover, the control unit is preferably adapted to actuate the battery to drive the current directly into the pressure transducer, substantially without charging a capacitor located at a placement site of the pressure transducer. In particular, the control unit is preferably adapted to actuate the battery to drive the current directly into the pressure transducer, substantially without charging a capacitor located at a placement site of the pressure transducer having capacitance greater than 0.1 nF.
- Additionally, in a preferred embodiment, the control unit is adapted to actuate the battery to drive current into the pressure transducer during a plurality of current-driving time periods, each less than 0.5 p, and to sense respective electrical characteristics of the pressure transducer during each of the current-driving time periods. In this case, the battery is preferably adapted to drive the current directly into the pressure transducer, substantially without charging a capacitor located at a placement site of the pressure transducer during each of the current-driving time periods.
- For some applications, the control unit is adapted to actuate the battery to drive current through the pressure transducer during a plurality of current-driving time periods, each less than 0.5 p. Additionally, a duty cycle of the control unit (defined by a length of one of the current-driving time periods divided by a time between the initiation of two successive current-driving time periods) is preferably less than 0.3%, or even less than 0.03%.
- In a preferred embodiment, the apparatus includes a signal processor, adapted to be placed in the patient at a common placement site with the pressure transducer and to process the sensed electrical characteristic. For example, the signal processor may include an amplifier, adapted to amplify the sensed electrical characteristic. Alternatively or additionally, the signal processor includes a microprocessor. In this case, the apparatus preferably includes:
- a first set of wires, adapted to couple the control unit to the microprocessor; and
- a second set of wires, adapted to couple the microprocessor to the pressure transducer,
- wherein the number of wires in the second set of wires is greater than the number of wires in the first set of wires.
- As appropriate, the control unit may be adapted to set the current-driving time period to be less than 0.1 p, less than 0.02 p, or even less than 0.004 p.
- In some preferred embodiments of the present invention, the control unit is adapted: (a) to actuate the battery to drive current through the pressure transducer during a plurality of current-driving time periods, each less than 0.5 p, (b) to sense respective electrical characteristics of the pressure transducer during each of the current-driving time periods, and (c) to space the current-driving time periods by at least ten milliseconds. For some applications, the control unit is adapted to space the current-driving time periods by at least one second, by at least one minute, or even by at least one hour.
- There is further provided, in accordance with a preferred embodiment of the present invention, pressure-measuring apparatus, including:
- a pressure transducer, which is adapted to be placed at a pressure-sensing site in a patient, the pressure transducer having a characteristic mechanical response bandwidth f, and a corresponding mechanical response period p equal to 1/f; and
- a control unit, adapted to be placed at a control-unit site at least 3 cm from the pressure-sensing site, to drive current through the pressure transducer for a current-driving time period less than 0.5 p, and to sense an electrical characteristic of the pressure transducer during the current-driving time period.
- In a preferred embodiment, the control unit is adapted to be placed at a control-unit site which is at least 5 cm from the pressure-sensing site.
- There is still further provided, in accordance with a preferred embodiment of the present invention, pressure-measuring apparatus, including:
- a battery;
- a pressure transducer, which is adapted to be placed in a patient; and
- a control unit, which is adapted to actuate the battery to drive current through the pressure transducer for a current-driving time period less than 1000 microseconds, and to sense an electrical characteristic of the pressure transducer during the current-driving time period.
- For some applications, the control unit is adapted to set the current-driving time period to be less than 250 microseconds, less than 50 microseconds, less than 10 microseconds, or even less than 2 microseconds.
- There is yet further provided, in accordance with a preferred embodiment of the present invention, pressure-measuring apparatus, including:
- a pressure transducer, which is adapted to be placed at a pressure-sensing site in a patient; and
- a control unit, adapted to be placed at a control-unit site at least 3 cm from the pressure-sensing site, to drive current through the pressure transducer for a current-driving time period less than 1000 microseconds, and to sense an electrical characteristic of the pressure transducer during the current-driving time period.
- There is also provided, in accordance with a preferred embodiment of the present invention, a method for measuring pressure via a pressure transducer, placed in a patient, the pressure transducer having a characteristic mechanical response bandwidth f, and a corresponding mechanical response period p equal to 1/f, the pressure transducer being coupled to a battery, the method including:
- actuating the battery to drive current through the pressure transducer for a current-driving time period less than 0.5 p; and
- sensing an electrical characteristic of the pressure transducer during the current-driving time period.
- There is additionally provided, in accordance with a preferred embodiment of the present invention, a method for measuring pressure via a pressure transducer, placed in a patient at a pressure-sensing site, the pressure transducer having a characteristic mechanical response bandwidth f, and a corresponding mechanical response period p equal to 1/f, the method including:
- from a control-unit site at least 3 cm from the pressure-sensing site, driving current through the pressure transducer for a current-driving time period less than 0.5 p; and
- sensing an electrical characteristic of the pressure transducer during the current-driving time period.
- There is still additionally provided, in accordance with a preferred embodiment of the present invention, a method for measuring pressure via a pressure transducer, placed in a patient, the pressure transducer being coupled to a battery, the method including:
- actuating the battery to drive current through the pressure transducer for a current-driving time period less than 1000 microseconds; and
- sensing an electrical characteristic of the pressure transducer during the current-driving time period.
- There is yet additionally provided, in accordance with a preferred embodiment of the present invention, apparatus which is adapted to be placed in a patient, including:
- circuitry, which is adapted to be placed in a patient;
- a lead wire; and
- an electrically-conductive connector, which is crimped to the lead wire so as to be electrically coupled thereto, and which is soldered to the circuitry.
- Typically, the lead wire includes an MP35N lead wire, a platinum/iridium lead wire, or a wire including 1-60% iron by weight.
- In a preferred embodiment, the connector includes a hollow tube, wherein a portion of the lead wire is disposed within the hollow tube, and wherein the hollow tube is crimped to the portion of the lead wire. Typically, but not necessarily, the connector includes stainless steel.
- For some applications, the circuitry is adapted to be implanted in the patient. For other applications, the circuitry is adapted to be incorporated in a catheter.
- In a preferred embodiment, the circuitry includes a sensor, such as a pressure sensor, a temperature sensor, and/or a chemical sensor. Alternatively or additionally, the sensor includes an electrode, adapted to sense electrical activity in tissue of the patient where the apparatus is placed. Further alternatively or additionally, the sensor includes a flow sensor, adapted to sense a flow of blood in a vicinity of the apparatus.
- For some applications, the circuitry includes an active element, such as a stimulating electrode, a light source adapted to facilitate photodynamic therapy, an electroactive polymer, and/or a mechanical actuator.
- There is also provided, in accordance with a preferred embodiment of the present invention, apparatus which is adapted to be placed in a patient, including:
- circuitry, which is adapted to be placed in the patient;
- a lead wire, selected from the group consisting of: an MP35N lead wire, a platinum/iridium lead wire, and lead wire including 1-60% iron by weight; and
- solder, including at least 20% indium by weight, for electrically coupling the lead wire to the circuitry.
- In a preferred embodiment, the solder includes at least 50% indium.
- There is further provided, in accordance with a preferred embodiment of the present invention, apparatus which is adapted to be placed in a patient, including:
- an electronic device;
- a gel; and
- a hollow casing, one or more holes being disposed in a wall thereof, inside which casing the electronic device and the gel are disposed, the casing being configured to facilitate flow of some of the gel out of the one or more holes when the casing is being filled with the gel.
- Preferably, the apparatus includes including a flexible covering, adapted to fit around at least a portion of the hollow casing. In a preferred embodiment, the flexible covering includes a flexible silicon covering.
- Typically, the hollow casing includes a rigid hollow casing, e.g., a hollow stainless steel casing.
- For some applications, the circuitry includes a pressure sensor, disposed within the casing such that pressure changes at a patient site where the apparatus is placed are conveyed to the pressure transducer via the gel.
- In a preferred embodiment, a sensing hole is disposed in the hollow casing, and a substantially non-metallic flexible covering is disposed outside the casing, so as to cover the sensing hole and to convey pressure changes at the patient site through the sensing hole to the gel. The diameter of the sensing hole is typically less than 2 mm.
- The present invention will be more fully understood from the following detailed description of the preferred embodiments thereof, taken together with the drawings, in which:
- FIG. 1 is a schematic diagram of an implanted pressure measuring system, in accordance with a preferred embodiment of the present invention;
- FIGS. 2A and 2B are illustrative examples of power signals driven into a sensing device by a control unit, in accordance with a preferred embodiment of the present invention;
- FIGS. 3A and 3B are schematic diagrams of a connection system between MP35N wires and a chip, in accordance with a preferred embodiment of the present invention;
- FIGS. 4A and 4B are schematic diagrams of another connection system between MP35N wires and a chip, in accordance with a preferred embodiment of the present invention; and
- FIG. 5 is a sectional schematic diagram of an implantable pressure transducer, in accordance with a preferred embodiment of the present invention.
- FIG. 1 is a schematic diagram of an implanted
pressure measurement system 100, in accordance with a preferred embodiment of the present invention. The example shown is a system for measuring pressure in theurinary bladder 110 of a patient, although it is to be appreciated thatsystem 100 could be implanted to measure pressure at any of a number of appropriate sites in the patient's body, e.g., at a cardiac site. -
System 100 typically includes an implantable orexternal control unit 102 including asignal generator 104, asignal analysis unit 106, and animplantable pressure sensor 114. Typically,pressure sensor 114 includes a piezoresistive element RX which is electrically connected as one element in a Wheatstone bridge circuit arrangement. For some applications, two or more piezoresistive elements are incorporated into corresponding respective positions in a Wheatstone bridge. Apower source 118 is preferably included withincontrol unit 102, and is coupled to provide energy to signalgenerator 104 andsignal analysis unit 106 from rechargeable or non-rechargeable batteries or another replaceable or renewable source of power. -
Signal generator 104 sends pulsed signals topressure sensor 114.Pressure sensor 114, which includes piezoresistive element RX whose resistance is a function of the pressure imposed upon it, returns a voltage signal (measured between points B and C in the Wheatstone bridge) to controlunit 102 commensurate with the value of resistance RX at the instant of measurement. This voltage signal is amplified and input to signalanalysis unit 106 where it is interpreted as a pressure measurement. - Typically, Wheatstone bridges used in prior art implantable medical devices require a relatively large amount of power to operate, as it is the practice to apply power generally continuously, and to sample intermittently, in order to obtain a signal. Thus, continuous monitoring with a Wheatstone bridge is not efficient in an implanted device, which necessarily has a limited power supply. The positive aspects of a Wheatstone bridge, namely that it is simple, inexpensive, and sensitive to small changes, have therefore not been able to be efficiently utilized using the continuous-operation modes associated therewith in the prior art.
- In order to take advantage of the positive aspects of the Wheatstone bridge, while minimizing power consumption, preferred embodiments of the present invention provide for current to be driven through the Wheatstone bridge and for measurements to be taken intermittently, as opposed to continuously. Thus, signals are preferably driven from
signal generator 104 topressure sensor 114 in the form of intermittent pulses. - The delay between successive pressure readings is preferably determined based on the particular application. For example, a single daily blood pressure measurement may be sufficient for some applications, such that the total power requirement is negligible. Cardiac pressure measurements, intended for example to track heart failure, may be performed at 5 Hz. A system for identifying the onset of stress incontinence may sample at 30 Hz. Further, because action potential propagation is associated with mechanical deformations of axons, pressure changes responsive to these deformations may be sampled at 2000 Hz.
- In general, these embodiments of the present invention are significantly more efficient than piezoresistive pressure-sampling methods known in the art, because these embodiments commonly perform sampling during intermittent short time periods whose reciprocals correspond to
sampling rates 2, 100, or even 1000 times higher than the characteristic mechanical response bandwidth of the piezoresistive pressure sensors For example, in a preferred embodiment of the present invention which samples during intermittent 10 μsec periods, a sampling pseudo-frequency of 100 kHz is obtained (i.e., the reciprocal of 10 μsec), far above a 1 kHz bandwidth characteristic of many piezoresistive pressure sensors which are ready for implantation. - It is noted that, in the context of the present patent application and in the claims, the term “characteristic mechanical response bandwidth” refers to the bandwidth in a fully-assembled pressure-sensing device, and not to the theoretical bandwidth attainable, for example, by a piezoresistive circuit unencumbered by gel or supporting structure. Thus, although a given piezoresistive circuit may have a theoretical bandwidth of 10 kHz, once it is incorporated into a fully-assembled pressure-sensing device, the characteristic mechanical response bandwidth of the device would be closer to 1 kHz.
- Prior art piezoresistive sampling techniques, by contrast, do not generally drive current through piezoresistive sensors and attempt sampling during time periods whose reciprocals correspond to frequencies substantially faster than the characteristic mechanical response bandwidth of the piezoresistive material. The realization by the inventors that the mechanical frequency response can be decoupled from the electrical bandwidth without adding other heat-dissipating components, so as to enable fast and efficient intermittent sampling, provides a substantial improvement in characteristics of the implanted device over implanted devices known in the art. It is noted that the above-cited U.S. Pat. No. 4,432,372 to Monroe uses fast sampling for a very different purpose (to enable time-sharing of lead wires), and requires the energy-consuming process of charging and discharging of a capacitor to enable every pressure measurement.
- FIGS. 2A and 2B show an illustrative example of a preferred pulse waveform to facilitate measuring pressure in the bladder of a patient, in accordance with a preferred embodiment of the present invention. For some applications,
signal generator 104 sends pulses to pressuresensor 114 at a driving rate of 32 Hz (FIG. 2A), although it is to be understood that other driving rates (e.g., between 10 μHz and 3 kHz) may also be used, as appropriate for a particular application. - A typical stabilization period for a preferred piezoresistive device upon which pressure is imposed is approximately 1 μsec. A suitable definition of “stabilization period” for most applications is the time from the first application of current to
sensor 114 until the time when the output of the sensor reaches 90% of maximum. In a preferred embodiment, a constant-pressure calibration period ofsensor 114 is provided, in which samples are taken at various times after the first application of current to the sensor (e.g., every 100 nanoseconds), until the samples reach a steady-state value. Preferably, a calibration function C(t) is thus determined, to facilitate corrections to be made to data which are sampled during the stabilization period during regular operation ofsensor 114. For example, C(t) may represent the percentage of the steady-state pressure reading, such that a corrected pressure reading based on a data point x recorded at t=200 nanoseconds after the first application of current would simply be x/C(t). Advantageously, this method allows the total time during which current is driven throughpressure sensor 114 to be very short, e.g., only several tens or hundreds of nanoseconds. - FIG. 2B is a magnified schematic of a typical pulse shown in FIG. 2A with a sampling time of 10 μsec. For this signal frequency and waveform, the total time that the pressure sensor is activated during one second is the stabilization time plus the sampling time multiplied by the frequency, or 11 μsec×32=352 μsec. Thus, in the embodiment shown in FIG. 2B, no data are typically recorded during the stabilization period. It can be seen that, in comparison to constant pressure sensor activation, as is known in the art, the total power consumption in this example is reduced by a factor of 1/0.000352 or almost 3000. Thus, the issue of power consumption, a major consideration in design of prior art active devices implanted in patients, is significantly reduced in preferred embodiments of the present invention.
- In the illustrative examples described above, a low power consumption pressure sensor is described in a preferred embodiment utilizing a piezoresistive element and a Wheatstone bridge arrangement. This is considered as illustrative only of certain aspects of the invention. Since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the invention to the exact construction and operation shown and described. Accordingly, all suitable modifications and equivalents in materials and circuitry that enable a change in resistance or another parameter to be utilized to measure changes in pressure in an implanted device utilizing a low measurement duty cycle may be considered to fall within the scope of the invention. Preferred duty cycles are typically, but not necessarily, below 0.3% or even 0.03%.
- Reference is now made to FIGS. 3A and 3B, which are schematic drawings of a
connection system 120 for use, for example, in the implantable pressure sensor described hereinabove with reference to FIG. 1, in accordance with a preferred embodiment of the present invention. It is to be understood, however, that the apparatus and methods described with reference to FIGS. 3A and 3B could alternatively or additionally be applied with a range of circuitry, such as, for example, a signal processor such as a microprocessor, sensors such as pressure sensors other than those described herein, temperature sensors, chemical sensors (e.g., glucose sensors), flow sensors, or sensing electrodes. Further alternatively or additionally,connection system 120 may be used in combination with active elements, such as, by way of illustration and not limitation, actuators, stimulating electrodes, electroactive polymers, or light sources for photodynamic therapy. - In accordance with a preferred embodiment of the present invention,
connection system 120 provides means for connectingcontrol unit 102 to pressure sensor 114 (FIG. 1) viaMP35N wires 128. MP35N is a preferred alloy for implantable medical devices. Preferably, the pressure sensing means is included in achip 124, which is fixed to acircuit board 122 including four copperconductive elements 126.Conductive elements 126 are, in turn, coupled to four ormore wires 134 which function to transmit signals to and fromchip 124. -
Coupling MP35N wires 128 toconductive elements 126 is optimally not accomplished by direct soldering, as MP35N wires do not solder satisfactorily to copper. Thus, astainless steel cylinder 130 is mechanically coupled to the end of each MP35N wire, for example via crimping (FIG. 3B), so as to achieve good electrical contact therewith, and the cylinder is subsequently coupled toconductive elements 126 by asolder joint 132, using techniques known in the art. It is noted that stainless steel can be satisfactorily soldered to copper and is also suitable for chronic implantation in the human body, using known procedures. To obtain improved electrical conduction,cylinders 130 are preferably coated with gold prior to soldering. Alternatively,cylinders 130 are treated with phosphoric acid to improve electrical conduction.Wires 128 are also preferably coated with a substance such as Teflon using standard methods so as to prevent short circuits between the wires. Additionally, the portion ofwires 128 between the circuit board and the control unit are preferably wound together into a coil and enclosed in aflexible tube 136 for further protection and ease of handling during implantation. - FIG. 4A is a schematic drawing of a
connection system 140 for use, for example, in the implantable pressure sensor described hereinabove with reference to FIG. 1, in accordance with a preferred embodiment of the present invention. Alternatively or additionally, it will be appreciated that other medical applications, such as those described hereinabove with reference to FIGS. 3A and 3B, may also be facilitated through the use ofconnection system 140. - In accordance with a preferred embodiment of the present invention,
MP35N wires 128 are used to electricallycouple control unit 102 topressure sensor 114, as described with reference to FIGS. 3A and 3B. This coupling is not optimally achieved by simply soldering MP35N wires to standard copper connectors, as MP35N does not solder satisfactorily to copper using standard tin solder. The inventors have found that MP35N wires do solder satisfactorily when the solder includes a substantial quantity of indium. Therefore,connection system 140, including achip 144 includingpressure sensor 114, is preferably soldered withindium solder joints 148 toconductive elements 146 of acircuit board 142.Chip 144, in turn, is preferably electrically coupled toconductive elements 146 by small connectingwires 150. Preferably,solder joints 148 include at least 10% indium by weight (typically 50-100% indium). - FIG. 4B is a schematic drawing of a
connection system 240, in accordance with a preferred embodiment of the present invention.System 240 is generally similar tosystem 140, described hereinabove with reference to FIG. 4A, except for differences as noted.Circuit board 142 comprises asignal processor 202, which, in turn, comprises amicroprocessor 204 and anamplifier 200.Amplifier 200 preferably amplifies a voltage drop v(t) generated during operation of chip 144 (e.g., responsive to pressure changes applied to a piezoresistive element), andmicroprocessor 204 digitizes the amplified signal. Advantageously, the number ofwires 128coupling control unit 102 tocircuit board 142 can by these means be reduced, with no loss in functionality. In a preferred embodiment, only twowires 128couple control unit 102 tomicroprocessor 204, and these wires carry power to the microprocessor, in order to facilitate the microprocessor's operations. For example, the microprocessor may be coupled to the control unit by the twowires 128, and to apressure sensor 114 inchip 144 by fourconductors 147. Results of the pressure sensing are then preferably conveyed bymicroprocessor 204 to the control unit by applying a modulation signal onto the twowires 128 that carry power to the microprocessor. Further advantageously, whencircuit board 142 includes a microprocessor, especially in combination with an amplifier, the noise which might otherwise corrupt a low-amplitude analog signal to some extent during its propagation to controlunit 102 is substantially reduced. - It is noted in this respect that these aspects of
connection system 240 may be incorporated into catheter apparatus (not shown), or other non-implanted sensing or active devices, so as to benefit from the reduced signal noise and wire-count which are attainable by performing processing at the actual sensed or treated site. By contrast, standard techniques perform substantially all of their processing remote from the sensed or treated site. In a preferred embodiment, a catheter has a pressure sensor, microprocessor, and amplifier, at the distal end thereof, constructed using techniques described herein, and conveys digitized pressure readings to a control unit external to the patient's body, preferably via only two leads coupling the microprocessor and the control unit. - FIG. 5 is a sectional schematic drawing of an
implantable device 160, in accordance with a preferred embodiment of the present invention.Device 160 includeschip 124, which preferably contains a pressure-sensing element, andconnection system 120 to transmit pressure data to a control unit (not shown), as described hereinabove with reference to FIGS. 3A and 3B. Applications other than pressure sensing, such as those described with reference to FIGS. 3A and 3B, may be alternatively or additionally incorporated intodevice 160. Thus, for example,device 160 may include an implantable temperature or chemical sensor, or an implantable electrode. - A
stainless steel cylinder 166 is used to protect the chip and the connection system during implantation in the body, and, subsequently, from the physiological environment inside the patient's body.Cylinder 166 provides a rigid surface to which to fastencircuit board 122, thus providing a stable base forchip 124, which includes pressure-sensing apparatus. Preferably, a UV-hardenedglue 172 is used to increase the mechanical strength of connections in the device. A pressure-sensing hole 168 is present incylinder 166, typically adjacent to the pressure-sensing apparatus ofchip 124, so that the pressure of the surrounding tissue can be sensed.Hole 168 may be, for example, 1.8 mm in diameter. - Two fill
holes 170 incylinder 166 are used to fillcylinder 166 with a pressure transducing substance, preferably asilicon gel 174. A plurality of holes are used so that asgel 174 is fed in onehole 170, any trapped air or excess gel can exit theother hole 170 orhole 168. It is preferred to remove all air bubbles fromcylinder 166 in order to obtain a uniform medium in the cylinder and thereby facilitate the accurate measurement of the pressure external tocylinder 166. Electrical components insidecylinder 166 are protected from moisture by a thin coating such as parylene, typically several microns deep. To maintain the integrity ofgel 174 and prevent contaminants from the body from enteringcylinder 166 throughhole 168 orholes 170,cylinder 166 is preferably encased in a flexible covering such as aflexible tube 162, capable of conveying body pressures to the pressure sensing apparatus insidecylinder 166. In a preferred embodiment,tube 162 includes silicon, and asilicon glue cap 164 is placed at one end oftube 166 following the placement of the gel incylinder 166. Moreover, the flexible covering is preferably largely non-metallic. - It is noted that the method described in this preferred embodiment of the present invention for filling
gel 174 in one hole while allowing it to escape through another hole, followed by placing a flexible tube around the pressure chamber (cylinder 166) stands in contrast to many techniques known in the art for building implantable pressure sensors. In accordance with these prior art techniques, a pressure chamber is filled with a gel, after which a thin, fragile, metal plate is placed over the chamber. Disadvantages associated with these prior art techniques include difficulties in removing air bubbles from the gel, as well as the need to take extra measures to avoid damaging the thin metal plate. - In a preferred embodiment, the apparatus or methods described herein for measuring physiological pressures, for other sensing tasks, or for applying currents or for other active tasks, are used to facilitate corresponding operations, such as those described in the above-cited US patent application, entitled, “Pelvic disorder treatment device,” filed Nov. 29, 2001, which shares common inventorship with the inventorship of the present patent application, is assigned to the assignee of the present patent application, and is incorporated herein by reference.
- It is noted that whereas some preferred embodiments of the present invention are described with respect to implantable apparatus by way of illustration and not limitation, the scope of the present invention includes non-implantable apparatus as well. For example, pressure transducers described herein as implantable may also be incorporated into catheters.
- It is also noted that whereas some techniques of the present invention are described hereinabove with respect to a pressure transducer, this is by way of illustration and not limitation. The scope of the present invention includes using the techniques described herein with other medical apparatus, such as medical sensors or medical active devices.
- It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Claims (276)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/761,005 US20040152999A1 (en) | 2001-11-29 | 2004-01-20 | Low power consumption implantable pressure sensor |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/996,668 US6862480B2 (en) | 2001-11-29 | 2001-11-29 | Pelvic disorder treatment device |
US10/076,869 US6712772B2 (en) | 2001-11-29 | 2002-02-15 | Low power consumption implantable pressure sensor |
US10/761,005 US20040152999A1 (en) | 2001-11-29 | 2004-01-20 | Low power consumption implantable pressure sensor |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/076,869 Continuation US6712772B2 (en) | 2001-11-29 | 2002-02-15 | Low power consumption implantable pressure sensor |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040152999A1 true US20040152999A1 (en) | 2004-08-05 |
Family
ID=32775396
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/076,869 Expired - Lifetime US6712772B2 (en) | 2001-11-29 | 2002-02-15 | Low power consumption implantable pressure sensor |
US10/761,005 Abandoned US20040152999A1 (en) | 2001-11-29 | 2004-01-20 | Low power consumption implantable pressure sensor |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/076,869 Expired - Lifetime US6712772B2 (en) | 2001-11-29 | 2002-02-15 | Low power consumption implantable pressure sensor |
Country Status (1)
Country | Link |
---|---|
US (2) | US6712772B2 (en) |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060247723A1 (en) * | 2005-04-28 | 2006-11-02 | Medtronic, Inc. | Flexible tube sensor for sensing urinary sphincter pressure |
US20060247682A1 (en) * | 2005-04-28 | 2006-11-02 | Medtronic, Inc. | Tube sensor for penile tumescence |
US20060247725A1 (en) * | 2005-04-28 | 2006-11-02 | Medtronic, Inc. | Multi-tube sensor for sensing urinary sphincter and urethral pressure |
US20060247724A1 (en) * | 2005-04-28 | 2006-11-02 | Medtronic, Inc. | Implantable optical pressure sensor for sensing urinary sphincter pressure |
US20070142728A1 (en) * | 2003-04-14 | 2007-06-21 | Avi Penner | Apparatus and methods using acoustic telemetry for intrabody communications |
US20070142727A1 (en) * | 2005-12-15 | 2007-06-21 | Cardiac Pacemakers, Inc. | System and method for analyzing cardiovascular pressure measurements made within a human body |
US20070252713A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | External voiding sensor system |
US20070255176A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Voiding detection with learning mode |
US20080021972A1 (en) * | 2006-07-21 | 2008-01-24 | Cardiac Pacemakers, Inc. | System and method for addressing implantable devices |
US20090021226A1 (en) * | 2007-07-19 | 2009-01-22 | Mitsutoshi Fujita | Semiconductor integrated circuit and sensor driving/measuring system |
US7522061B2 (en) | 2006-04-28 | 2009-04-21 | Medtronic, Inc. | External voiding sensor system |
US20090177251A1 (en) * | 2008-01-07 | 2009-07-09 | Paul Huelskamp | System And Method For In Situ Trimming Of Oscillators In A Pair Of Implantable Medical Devices |
US20090198307A1 (en) * | 2008-02-06 | 2009-08-06 | Bin Mi | Direct inductive/acoustic converter for implantable medical device |
US7650185B2 (en) | 2006-04-25 | 2010-01-19 | Cardiac Pacemakers, Inc. | System and method for walking an implantable medical device from a sleep state |
US20100042177A1 (en) * | 2008-08-14 | 2010-02-18 | Cardiac Pacemakers, Inc. | Performance assessment and adaptation of an acoustic communication link |
US7742815B2 (en) | 2005-09-09 | 2010-06-22 | Cardiac Pacemakers, Inc. | Using implanted sensors for feedback control of implanted medical devices |
US7756587B2 (en) | 2000-10-16 | 2010-07-13 | Cardiac Pacemakers, Inc. | Systems and methods for communicating with implantable devices |
US20100244813A1 (en) * | 2009-03-30 | 2010-09-30 | Pcb Piezotronics, Inc. | Bridge sensor with collocated electronics and two-wire interface |
US7813808B1 (en) | 2004-11-24 | 2010-10-12 | Remon Medical Technologies Ltd | Implanted sensor system with optimized operational and sensing parameters |
US7890176B2 (en) | 1998-07-06 | 2011-02-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating chronic pelvic pain |
US20110066046A1 (en) * | 2009-09-16 | 2011-03-17 | Young Darrin J | Implantable flat blood pressure sensing cuff structure and implantable blood pressure monitoring device using the cuff structure |
US7930031B2 (en) | 2000-10-16 | 2011-04-19 | Remon Medical Technologies, Ltd. | Acoustically powered implantable stimulating device |
USRE42378E1 (en) | 2000-10-16 | 2011-05-17 | Remon Medical Technologies, Ltd. | Implantable pressure sensors and methods for making and using them |
US7948148B2 (en) | 1997-12-30 | 2011-05-24 | Remon Medical Technologies Ltd. | Piezoelectric transducer |
US7955268B2 (en) | 2006-07-21 | 2011-06-07 | Cardiac Pacemakers, Inc. | Multiple sensor deployment |
US8078278B2 (en) | 2006-01-10 | 2011-12-13 | Remon Medical Technologies Ltd. | Body attachable unit in wireless communication with implantable devices |
US8271093B2 (en) | 2004-09-17 | 2012-09-18 | Cardiac Pacemakers, Inc. | Systems and methods for deriving relative physiologic measurements using a backend computing system |
US8340776B2 (en) | 2007-03-26 | 2012-12-25 | Cardiac Pacemakers, Inc. | Biased acoustic switch for implantable medical device |
US8369960B2 (en) | 2008-02-12 | 2013-02-05 | Cardiac Pacemakers, Inc. | Systems and methods for controlling wireless signal transfers between ultrasound-enabled medical devices |
US8380312B2 (en) | 2009-12-31 | 2013-02-19 | Ams Research Corporation | Multi-zone stimulation implant system and method |
US8593107B2 (en) | 2008-10-27 | 2013-11-26 | Cardiac Pacemakers, Inc. | Methods and systems for recharging an implanted device by delivering a section of a charging device adjacent the implanted device within a body |
US8591423B2 (en) | 2008-10-10 | 2013-11-26 | Cardiac Pacemakers, Inc. | Systems and methods for determining cardiac output using pulmonary artery pressure measurements |
US8632470B2 (en) | 2008-11-19 | 2014-01-21 | Cardiac Pacemakers, Inc. | Assessment of pulmonary vascular resistance via pulmonary artery pressure |
US8725260B2 (en) | 2008-02-11 | 2014-05-13 | Cardiac Pacemakers, Inc | Methods of monitoring hemodynamic status for rhythm discrimination within the heart |
US8731646B2 (en) | 2004-02-05 | 2014-05-20 | Earlysense Ltd. | Prediction and monitoring of clinical episodes |
US8734360B2 (en) | 2007-05-02 | 2014-05-27 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US8798761B2 (en) | 2008-06-27 | 2014-08-05 | Cardiac Pacemakers, Inc. | Systems and methods of monitoring the acoustic coupling of medical devices |
US8821418B2 (en) | 2007-05-02 | 2014-09-02 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US8882684B2 (en) | 2008-05-12 | 2014-11-11 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US9457186B2 (en) | 2010-11-15 | 2016-10-04 | Bluewind Medical Ltd. | Bilateral feedback |
US9629560B2 (en) | 2015-04-06 | 2017-04-25 | Thomas Jefferson University | Implantable vital sign sensor |
US9731112B2 (en) | 2011-09-08 | 2017-08-15 | Paul J. Gindele | Implantable electrode assembly |
CN107348959A (en) * | 2016-05-09 | 2017-11-17 | 上银科技股份有限公司 | Physiological signal sensing device and its operation method of start and shutdown |
US9883809B2 (en) | 2008-05-01 | 2018-02-06 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US10292625B2 (en) | 2010-12-07 | 2019-05-21 | Earlysense Ltd. | Monitoring a sleeping subject |
US10335043B2 (en) | 2015-04-06 | 2019-07-02 | Thomas Jefferson University | Implantable vital sign sensor |
US11000195B2 (en) | 2015-04-06 | 2021-05-11 | Thomas Jefferson University | Implantable vital sign sensor |
US11330987B2 (en) | 2015-04-06 | 2022-05-17 | Thomas Jefferson University | Implantable vital sign sensor |
Families Citing this family (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050055063A1 (en) * | 2001-07-20 | 2005-03-10 | Loeb Gerald E. | Method and apparatus for the treatment of urinary tract dysfunction |
US8615294B2 (en) * | 2008-08-13 | 2013-12-24 | Bio Control Medical (B.C.M.) Ltd. | Electrode devices for nerve stimulation and cardiac sensing |
US8565896B2 (en) | 2010-11-22 | 2013-10-22 | Bio Control Medical (B.C.M.) Ltd. | Electrode cuff with recesses |
US6862480B2 (en) * | 2001-11-29 | 2005-03-01 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
US6712772B2 (en) * | 2001-11-29 | 2004-03-30 | Biocontrol Medical Ltd. | Low power consumption implantable pressure sensor |
AU2002356411A1 (en) * | 2002-05-07 | 2003-11-11 | Biocontrol Medical Ltd. | Low power consumption implantable pressure sensor |
US8880192B2 (en) | 2012-04-02 | 2014-11-04 | Bio Control Medical (B.C.M.) Ltd. | Electrode cuffs |
US8718791B2 (en) | 2003-05-23 | 2014-05-06 | Bio Control Medical (B.C.M.) Ltd. | Electrode cuffs |
US20050066746A1 (en) * | 2003-06-13 | 2005-03-31 | Dan Winter | Meter transmitter/receiver and method of manufacturing same for use in a water-containing environment |
US8751003B2 (en) * | 2004-02-11 | 2014-06-10 | Ethicon, Inc. | Conductive mesh for neurostimulation |
US7647112B2 (en) * | 2004-02-11 | 2010-01-12 | Ethicon, Inc. | System and method for selectively stimulating different body parts |
US7979137B2 (en) * | 2004-02-11 | 2011-07-12 | Ethicon, Inc. | System and method for nerve stimulation |
US8165695B2 (en) * | 2004-02-11 | 2012-04-24 | Ethicon, Inc. | System and method for selectively stimulating different body parts |
US20050177067A1 (en) * | 2004-02-11 | 2005-08-11 | Tracey Michael R. | System and method for urodynamic evaluation utilizing micro-electronic mechanical system |
US20050182342A1 (en) * | 2004-02-13 | 2005-08-18 | Medtronic, Inc. | Monitoring fluid flow in the gastrointestinal tract |
US20060020225A1 (en) * | 2004-07-20 | 2006-01-26 | Gerber Martin T | Wireless urodynamic monitoring system with automated voiding diary |
US8588930B2 (en) * | 2005-06-07 | 2013-11-19 | Ethicon, Inc. | Piezoelectric stimulation device |
US20070225616A1 (en) * | 2005-06-15 | 2007-09-27 | Alpine Biomed Corp. | Wireless urinary incontinence monitoring system |
US8095198B2 (en) * | 2006-01-31 | 2012-01-10 | Warsaw Orthopedic. Inc. | Methods for detecting osteolytic conditions in the body |
US8195296B2 (en) * | 2006-03-03 | 2012-06-05 | Ams Research Corporation | Apparatus for treating stress and urge incontinence |
WO2007126632A2 (en) * | 2006-04-04 | 2007-11-08 | Ams Research Corporation | A tunneling instrument for and method of subcutaneously passing a medical electrical lead |
US7918796B2 (en) | 2006-04-11 | 2011-04-05 | Warsaw Orthopedic, Inc. | Volumetric measurement and visual feedback of tissues |
US7397166B1 (en) | 2006-04-12 | 2008-07-08 | Pacesetter, Inc. | Electroactive polymer-actuated peristaltic pump and medical lead incorporating such a pump |
US20070265675A1 (en) * | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
US20080011297A1 (en) * | 2006-06-30 | 2008-01-17 | Scott Thomas Mazar | Monitoring physiologic conditions via transtracheal measurement of respiratory parameters |
US8160710B2 (en) | 2006-07-10 | 2012-04-17 | Ams Research Corporation | Systems and methods for implanting tissue stimulation electrodes in the pelvic region |
US20080077440A1 (en) * | 2006-09-26 | 2008-03-27 | Remon Medical Technologies, Ltd | Drug dispenser responsive to physiological parameters |
US20080132962A1 (en) * | 2006-12-01 | 2008-06-05 | Diubaldi Anthony | System and method for affecting gatric functions |
US8709631B1 (en) | 2006-12-22 | 2014-04-29 | Pacesetter, Inc. | Bioelectric battery for implantable device applications |
US8388670B1 (en) | 2007-01-16 | 2013-03-05 | Pacesetter, Inc. | Sensor/lead systems for use with implantable medical devices |
US20080177398A1 (en) * | 2007-01-24 | 2008-07-24 | Yossi Gross | Treatment of bladder dysfunction |
EP2155051A1 (en) * | 2007-06-14 | 2010-02-24 | Cardiac Pacemakers, Inc. | Intracorporeal pressure measurement devices and methods |
US9427573B2 (en) | 2007-07-10 | 2016-08-30 | Astora Women's Health, Llc | Deployable electrode lead anchor |
US20100049289A1 (en) | 2007-07-10 | 2010-02-25 | Ams Research Corporation | Tissue anchor |
CA2693198C (en) | 2007-07-27 | 2014-10-14 | Ams Research Corporation | Pelvic floor treatments and related tools and implants |
US8352026B2 (en) * | 2007-10-03 | 2013-01-08 | Ethicon, Inc. | Implantable pulse generators and methods for selective nerve stimulation |
US7918782B2 (en) * | 2007-11-15 | 2011-04-05 | Ams Research Corporation | Prosthesis with bladder that adjusts girth |
CA2724335A1 (en) * | 2008-05-15 | 2009-11-19 | Inspire Medical Systems, Inc. | Method and apparatus for sensing respiratory pressure in an implantable stimulation system |
WO2009145911A1 (en) * | 2008-05-29 | 2009-12-03 | Ams Research Corporation | Minimally invasive levator avulsion repair |
US20090312650A1 (en) * | 2008-06-12 | 2009-12-17 | Cardiac Pacemakers, Inc. | Implantable pressure sensor with automatic measurement and storage capabilities |
US20100023091A1 (en) * | 2008-07-24 | 2010-01-28 | Stahmann Jeffrey E | Acoustic communication of implantable device status |
WO2010030454A1 (en) * | 2008-09-12 | 2010-03-18 | Cardiac Pacemakers, Inc. | Chronically implanted abdominal pressure sensor for continuous ambulatory assessment of renal functions |
JP5575789B2 (en) | 2008-11-19 | 2014-08-20 | インスパイア・メディカル・システムズ・インコーポレイテッド | How to treat sleep-disordered breathing |
US8545391B2 (en) | 2008-12-23 | 2013-10-01 | Ams Research Corporation | Penile prosthesis implantation device |
AU2010216210B2 (en) | 2009-02-18 | 2013-01-31 | Boston Scientific Scimed, Inc. | Treatment of a pelvic condition through indirect electrical stimulation |
US20100217340A1 (en) * | 2009-02-23 | 2010-08-26 | Ams Research Corporation | Implantable Medical Device Connector System |
EP2416842B1 (en) | 2009-03-17 | 2017-07-05 | AMS Research Corporation | Electrode implantation tool |
US9539433B1 (en) | 2009-03-18 | 2017-01-10 | Astora Women's Health, Llc | Electrode implantation in a pelvic floor muscular structure |
US20100324378A1 (en) * | 2009-06-17 | 2010-12-23 | Tran Binh C | Physiologic signal monitoring using ultrasound signals from implanted devices |
WO2011003072A2 (en) | 2009-07-02 | 2011-01-06 | Ams Research Corporation | Electrode implantation in the urinary sphincter |
EP2295109A3 (en) | 2009-09-11 | 2011-05-25 | AMS Research Corporation | Tissue anchor |
US20110092840A1 (en) * | 2009-09-23 | 2011-04-21 | Feather Sensors Llc | Intelligent air flow sensors |
DE102010019796B4 (en) | 2010-05-06 | 2013-05-16 | Inomed Medizintechnik Gmbh | Control arrangement for intraoperative monitoring of pelvic nerve function |
SE537180C2 (en) * | 2010-11-12 | 2015-02-24 | St Jude Medical Systems Ab | Extracorporeal interface unit for an intravascular measurement system |
US9220887B2 (en) | 2011-06-09 | 2015-12-29 | Astora Women's Health LLC | Electrode lead including a deployable tissue anchor |
US9399135B2 (en) | 2011-07-12 | 2016-07-26 | Astora Women's Health, Llc | Electronic stimulator device pulse generator circuit |
WO2013025678A1 (en) | 2011-08-16 | 2013-02-21 | Ams Research Corporation | Electrode lead tissue anchor |
US8577458B1 (en) | 2011-12-07 | 2013-11-05 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with leadless heart rate monitoring |
US8630709B2 (en) | 2011-12-07 | 2014-01-14 | Cyberonics, Inc. | Computer-implemented system and method for selecting therapy profiles of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
US8918190B2 (en) | 2011-12-07 | 2014-12-23 | Cyberonics, Inc. | Implantable device for evaluating autonomic cardiovascular drive in a patient suffering from chronic cardiac dysfunction |
US8918191B2 (en) | 2011-12-07 | 2014-12-23 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration |
US8600505B2 (en) | 2011-12-07 | 2013-12-03 | Cyberonics, Inc. | Implantable device for facilitating control of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
US10188856B1 (en) | 2011-12-07 | 2019-01-29 | Cyberonics, Inc. | Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
US8700150B2 (en) | 2012-01-17 | 2014-04-15 | Cyberonics, Inc. | Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration |
US8571654B2 (en) | 2012-01-17 | 2013-10-29 | Cyberonics, Inc. | Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction |
EP2804525A4 (en) * | 2012-01-19 | 2015-12-09 | Volcano Corp | Interface devices, systems, and methods for use with intravascular pressure monitoring devices |
US20150018728A1 (en) | 2012-01-26 | 2015-01-15 | Bluewind Medical Ltd. | Wireless neurostimulators |
US9089426B2 (en) | 2012-03-21 | 2015-07-28 | Ams Research Corporation | Automated implantable penile prosthesis pump system |
US10143391B2 (en) | 2012-05-08 | 2018-12-04 | Case Western Reserve University | Implantable pressure sensor |
US8688212B2 (en) | 2012-07-20 | 2014-04-01 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation |
US9643008B2 (en) | 2012-11-09 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing post-exercise recovery through vagus nerve stimulation |
US8923964B2 (en) | 2012-11-09 | 2014-12-30 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation |
US9452290B2 (en) | 2012-11-09 | 2016-09-27 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation |
WO2014087337A1 (en) | 2012-12-06 | 2014-06-12 | Bluewind Medical Ltd. | Delivery of implantable neurostimulators |
US9643011B2 (en) | 2013-03-14 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation |
CN105208923B (en) | 2013-03-15 | 2019-02-05 | 火山公司 | Interface equipment, system and method for being used together with arteries and veins overpressure monitoring device |
EP2991723A4 (en) | 2013-05-03 | 2017-02-01 | Nevro Corporation | Molded headers for implantable signal generators, and associated systems and methods |
US10033469B2 (en) | 2013-08-29 | 2018-07-24 | Battelle Memorial Institute | Injectable acoustic transmission devices and process for making and using same |
US10033470B2 (en) * | 2013-08-29 | 2018-07-24 | Battelle Memorial Institute | Acoustic transmission devices and process for making and using same |
US9999773B2 (en) | 2013-10-30 | 2018-06-19 | Cyberonics, Inc. | Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters |
US9511228B2 (en) | 2014-01-14 | 2016-12-06 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing hypertension through renal denervation and vagus nerve stimulation |
US9409024B2 (en) | 2014-03-25 | 2016-08-09 | Cyberonics, Inc. | Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction |
US9272143B2 (en) | 2014-05-07 | 2016-03-01 | Cyberonics, Inc. | Responsive neurostimulation for the treatment of chronic cardiac dysfunction |
US9415224B2 (en) | 2014-04-25 | 2016-08-16 | Cyberonics, Inc. | Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction |
US9950169B2 (en) | 2014-04-25 | 2018-04-24 | Cyberonics, Inc. | Dynamic stimulation adjustment for identification of a neural fulcrum |
US9713719B2 (en) | 2014-04-17 | 2017-07-25 | Cyberonics, Inc. | Fine resolution identification of a neural fulcrum for the treatment of chronic cardiac dysfunction |
AU2015264561B2 (en) | 2014-05-20 | 2020-02-20 | Nevro Corporation | Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods |
US9770599B2 (en) | 2014-08-12 | 2017-09-26 | Cyberonics, Inc. | Vagus nerve stimulation and subcutaneous defibrillation system |
US9737716B2 (en) | 2014-08-12 | 2017-08-22 | Cyberonics, Inc. | Vagus nerve and carotid baroreceptor stimulation system |
US9533153B2 (en) | 2014-08-12 | 2017-01-03 | Cyberonics, Inc. | Neurostimulation titration process |
EP3191176B1 (en) | 2014-10-22 | 2024-04-10 | Nevro Corp. | Systems and methods for extending the life of an implanted pulse generator battery |
US9504832B2 (en) | 2014-11-12 | 2016-11-29 | Cyberonics, Inc. | Neurostimulation titration process via adaptive parametric modification |
US10101429B2 (en) | 2015-02-25 | 2018-10-16 | Battelle Memorial Institute | Acoustic transmission device and process for tracking selected hosts |
US9517344B1 (en) | 2015-03-13 | 2016-12-13 | Nevro Corporation | Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator |
US9993322B2 (en) | 2015-05-27 | 2018-06-12 | Coloplast A/S | Method of implanting a urinary control system through a single skin incision |
US10067112B2 (en) | 2015-09-30 | 2018-09-04 | Battelle Memorial Institute | Autonomous sensor fish to support advanced hydropower development |
US10105540B2 (en) | 2015-11-09 | 2018-10-23 | Bluewind Medical Ltd. | Optimization of application of current |
US10300277B1 (en) | 2015-12-14 | 2019-05-28 | Nevro Corp. | Variable amplitude signals for neurological therapy, and associated systems and methods |
US10236920B2 (en) | 2015-12-15 | 2019-03-19 | Battelle Memorial Institute | Signal transmitter and methods for transmitting signals from animals |
US11278004B2 (en) | 2015-12-15 | 2022-03-22 | Battelle Memorial Institute | Transmitters for animals and methods for transmitting from animals |
EP3374019B1 (en) | 2015-12-31 | 2021-12-22 | Nevro Corporation | Controller for nerve stimulation circuit and associated systems and methods |
CN109561822B (en) | 2016-05-31 | 2022-03-04 | 酷拉公司 | Implantable intraocular pressure sensor and method of use |
US10531639B2 (en) | 2016-08-25 | 2020-01-14 | Battelle Memorial Institute | Systems and methods for monitoring organisms within an aquatic environment |
US10124178B2 (en) | 2016-11-23 | 2018-11-13 | Bluewind Medical Ltd. | Implant and delivery tool therefor |
US20180353764A1 (en) | 2017-06-13 | 2018-12-13 | Bluewind Medical Ltd. | Antenna configuration |
US11633604B2 (en) | 2018-01-30 | 2023-04-25 | Nevro Corp. | Efficient use of an implantable pulse generator battery, and associated systems and methods |
WO2019227092A1 (en) * | 2018-05-25 | 2019-11-28 | The Cleveland Clinic Foundation | Sensing device for ambulatory urodynamics having a pressure sensitive housing |
US11058875B1 (en) | 2018-09-19 | 2021-07-13 | Nevro Corp. | Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods |
US11590352B2 (en) | 2019-01-29 | 2023-02-28 | Nevro Corp. | Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods |
US10933238B2 (en) | 2019-01-31 | 2021-03-02 | Nevro Corp. | Power control circuit for sterilized devices, and associated systems and methods |
US11533818B2 (en) | 2019-03-12 | 2022-12-20 | Battelle Memorial Institute | Sensor assemblies and methods for emulating interaction of entities within water systems |
US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
Citations (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2816997A (en) * | 1955-02-23 | 1957-12-17 | Waters Corp | Resistance thermometer |
US3662758A (en) * | 1969-06-30 | 1972-05-16 | Mentor Corp | Stimulator apparatus for muscular organs with external transmitter and implantable receiver |
US3831588A (en) * | 1972-10-16 | 1974-08-27 | Device Res Inc | Pressure sensing device |
US4407296A (en) * | 1980-09-12 | 1983-10-04 | Medtronic, Inc. | Integral hermetic impantable pressure transducer |
US4730389A (en) * | 1986-08-15 | 1988-03-15 | Medtronic, Inc. | Method for fabrication of an implantable hermetic transparent container |
US4825876A (en) * | 1988-02-23 | 1989-05-02 | Abbott Laboratories | Encapsulated blood pressure transducer |
US4873986A (en) * | 1987-04-01 | 1989-10-17 | Utah Medical Products | Disposable apparatus for monitoring intrauterine pressure and fetal heart rate |
US5037488A (en) * | 1989-07-15 | 1991-08-06 | Heraeus Sensor Gmbh | Temperature sensor construction |
US5094242A (en) * | 1988-11-07 | 1992-03-10 | Regents Of The University Of California | Implantable nerve stimulation device |
US5103835A (en) * | 1990-05-02 | 1992-04-14 | Nihon Kohden Corporation | Impedance monitoring device for preventing urinary incontinence |
US5184619A (en) * | 1986-11-10 | 1993-02-09 | Peritronics Medical, Inc. | Intrauterine pressure and fetal heart rate sensor |
US5211175A (en) * | 1988-11-07 | 1993-05-18 | Regents Of The University Of California | Method for implanting electra-acupuncture needle |
US5324326A (en) * | 1991-11-25 | 1994-06-28 | Telectronics Pacing Systems, Inc. | Pressure sensing pacing lead |
US5411538A (en) * | 1993-11-01 | 1995-05-02 | Intermedics, Inc. | Implantable medical device with detachable battery or electronic circuit |
US5411548A (en) * | 1993-01-11 | 1995-05-02 | Carman; Brent | Method of varying appropriate muscle strength of a person to alleviate urinary or fecal urgency or incontinence or vaginal or bladder spasms |
US5508476A (en) * | 1993-04-01 | 1996-04-16 | Plessey Semiconductors Limited | Mounting arrangement for semiconductor devices |
US5522266A (en) * | 1993-11-30 | 1996-06-04 | Medex, Inc. | Low cost pressure transducer particularly for medical applications |
US5566680A (en) * | 1995-09-22 | 1996-10-22 | Graphic Controls Corporation | Transducer-tipped intrauterine pressure catheter system |
US5658321A (en) * | 1995-06-09 | 1997-08-19 | Ventritex, Inc. | Conductive housing for implantable cardiac device |
US5726624A (en) * | 1996-07-01 | 1998-03-10 | Honeywell Inc. | Temperature sensor with internal rigid substrate |
US5807265A (en) * | 1996-01-09 | 1998-09-15 | Kabushiki Kaisha Tokai Rika Denki Seisakusho | Catheter having pressure detecting ability |
US5836886A (en) * | 1995-11-01 | 1998-11-17 | Kabushiki Kaisha Tokai Rika Denki Seisakusho | Catheter having a sensor |
US5851226A (en) * | 1996-10-22 | 1998-12-22 | Medtronic, Inc. | Temporary transvenous endocardial lead |
US5969591A (en) * | 1991-03-28 | 1999-10-19 | The Foxboro Company | Single-sided differential pressure sensor |
US5984711A (en) * | 1998-09-10 | 1999-11-16 | Scimed Life Systems, Inc. | Methods and apparatus for increasing wire diameter to improve connectability |
US6006135A (en) * | 1997-09-26 | 1999-12-21 | Medtronic, Inc. | Apparatus for interconnecting implantable electrical leads and medical device |
US6019729A (en) * | 1996-11-15 | 2000-02-01 | Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho | Sensor mechanism-equipped catheter |
US6128531A (en) * | 1998-04-01 | 2000-10-03 | Pacesetter, Inc. | Delivery of ICD shock capacitor energy via a controlled current source |
US6129658A (en) * | 1997-12-10 | 2000-10-10 | Varian Associates, Inc. | Method and apparatus creating a radioactive layer on a receiving substrate for in vivo implantation |
US6248083B1 (en) * | 1997-03-25 | 2001-06-19 | Radi Medical Systems Ab | Device for pressure measurements |
US6253108B1 (en) * | 1999-04-30 | 2001-06-26 | Intermedics Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US20020055764A1 (en) * | 1998-11-05 | 2002-05-09 | Dov Malonek | Multi-electrode lead |
US6477414B1 (en) * | 2001-04-26 | 2002-11-05 | Pacesetter, Inc. | Transformer assembly for implantable cardiac stimulation device |
US6712772B2 (en) * | 2001-11-29 | 2004-03-30 | Biocontrol Medical Ltd. | Low power consumption implantable pressure sensor |
US6764472B1 (en) * | 2000-01-11 | 2004-07-20 | Bard Access Systems, Inc. | Implantable refillable infusion device |
US6862480B2 (en) * | 2001-11-29 | 2005-03-01 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
US6915162B2 (en) * | 2000-11-16 | 2005-07-05 | St. Jude Medical Ab | Implantable medical device for measuring ventricular pressure |
US20060200200A1 (en) * | 2005-03-04 | 2006-09-07 | Malinowski Zdzislaw B | Hermetic implantable stimulator |
US7328068B2 (en) * | 2003-03-31 | 2008-02-05 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1227186A (en) | 1968-09-18 | 1971-04-07 | ||
US3640284A (en) | 1970-01-05 | 1972-02-08 | Philip A De Langis | Apparatus for electrotherapy of the pubococcygeus |
GB1434524A (en) | 1972-04-27 | 1976-05-05 | Nat Res Dev | Urinary control apparatus |
GB1452262A (en) | 1972-07-13 | 1976-10-13 | Devices Implants Ltd | Pessary ring electrode system |
US3941136A (en) | 1973-11-21 | 1976-03-02 | Neuronyx Corporation | Method for artificially inducing urination, defecation, or sexual excitation |
AT332528B (en) | 1974-10-18 | 1976-10-11 | Nemec Hans | ELECTROMEDICAL APPARATUS |
US3926178A (en) | 1975-01-17 | 1975-12-16 | Alvin N Feldzamen | Apparatus for aiding the voluntary exercising of sphincter muscles |
US3983865A (en) | 1975-02-05 | 1976-10-05 | Shepard Richard S | Method and apparatus for myofunctional biofeedback |
US3983881A (en) | 1975-05-21 | 1976-10-05 | Telectronics Pty. Limited | Muscle stimulator |
US4023562A (en) | 1975-09-02 | 1977-05-17 | Case Western Reserve University | Miniature pressure transducer for medical use and assembly method |
SE7604553L (en) | 1976-04-21 | 1977-10-22 | Svenska Utvecklings Ab | ELECTRICAL STIMULATOR FOR REDUCING INCONTINENCE |
US4136684A (en) | 1977-02-07 | 1979-01-30 | Scattergood Mark G | Linear electromyographic biofeedback system |
US4139006A (en) | 1977-03-18 | 1979-02-13 | Corey Arthur E | Female incontinence device |
US4222377A (en) | 1977-06-27 | 1980-09-16 | American Medical Systems, Inc. | Pressure regulated artificial sphincter systems |
US4153059A (en) | 1977-10-25 | 1979-05-08 | Minnesota Mining And Manufacturing Company | Urinary incontinence stimulator system |
US4157087A (en) | 1978-03-06 | 1979-06-05 | Med General, Inc. | Peripheral nerve stimulator |
US4165750A (en) | 1978-03-18 | 1979-08-28 | Aleev Leonid S | Bioelectrically controlled electric stimulator of human muscles |
US4177819A (en) | 1978-03-30 | 1979-12-11 | Kofsky Harvey I | Muscle stimulating apparatus |
US4290420A (en) | 1980-06-09 | 1981-09-22 | Alberto Manetta | Stress incontinence diagnostic and treatment device |
GB2099304B (en) | 1981-02-06 | 1985-01-30 | Cornwell George Herbert Ivan | Incontinence control devices |
US4406288A (en) | 1981-04-06 | 1983-09-27 | Hugh P. Cash | Bladder control device and method |
US4432372A (en) | 1981-08-28 | 1984-02-21 | Medtronic, Inc. | Two-lead power/signal multiplexed transducer |
US4688575A (en) | 1982-03-12 | 1987-08-25 | Duvall Wilbur E | Muscle contraction stimulation |
US4492233A (en) | 1982-09-14 | 1985-01-08 | Wright State University | Method and apparatus for providing feedback-controlled muscle stimulation |
US4571749A (en) | 1982-09-21 | 1986-02-25 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
US4731083A (en) | 1982-09-21 | 1988-03-15 | The Johns Hopkins University | Manually actuated hydraulic sphincter |
EP0109217A1 (en) | 1982-11-05 | 1984-05-23 | Craig Medical Products Limited | Female incontinence device |
US4542753A (en) | 1982-12-22 | 1985-09-24 | Biosonics, Inc. | Apparatus and method for stimulating penile erectile tissue |
US4515167A (en) | 1983-02-28 | 1985-05-07 | Hochman Joel S | Device for the development, training and rehabilitation of the pubococcygeal and related perineal musculature of the female |
DE3317118C2 (en) | 1983-05-06 | 1986-08-28 | Richard Wolf Gmbh, 7134 Knittlingen | Device for the treatment of the female incontinentia urinae |
US4607639A (en) | 1984-05-18 | 1986-08-26 | Regents Of The University Of California | Method and system for controlling bladder evacuation |
US4739764A (en) | 1984-05-18 | 1988-04-26 | The Regents Of The University Of California | Method for stimulating pelvic floor muscles for regulating pelvic viscera |
US4785828A (en) | 1986-10-06 | 1988-11-22 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
US5207103A (en) * | 1987-06-01 | 1993-05-04 | Wise Kensall D | Ultraminiature single-crystal sensor with movable member |
US5113868A (en) * | 1987-06-01 | 1992-05-19 | The Regents Of The University Of Michigan | Ultraminiature pressure sensor with addressable read-out circuit |
US4846191A (en) | 1988-05-27 | 1989-07-11 | Data Sciences, Inc. | Device for chronic measurement of internal body pressure |
US4881526A (en) | 1988-05-27 | 1989-11-21 | Empi, Inc. | Intravaginal electrode and stimulation system for controlling female urinary incontinence |
DE69128213T2 (en) | 1990-05-26 | 1998-06-18 | Med El Medical Electronics Ele | Device for neuromuscular electrical stimulation |
US6131575A (en) | 1991-01-10 | 2000-10-17 | The Procter & Gamble Company | Urinary incontinence device |
US5452719A (en) | 1991-07-23 | 1995-09-26 | Eisman; Eugene | Multiple electrode myographic probe and method |
US5330505A (en) | 1992-05-08 | 1994-07-19 | Leonard Bloom | System for and method of treating a malfunctioning heart |
GB9211085D0 (en) | 1992-05-23 | 1992-07-08 | Tippey Keith E | Electrical stimulation |
US5484445A (en) | 1993-10-12 | 1996-01-16 | Medtronic, Inc. | Sacral lead anchoring system |
US5423329A (en) | 1994-04-15 | 1995-06-13 | Rehab Centers Of America, Inc. | Method of treatment for urinary incontinence |
US5591217A (en) | 1995-01-04 | 1997-01-07 | Plexus, Inc. | Implantable stimulator with replenishable, high value capacitive power source and method therefor |
US5564434A (en) | 1995-02-27 | 1996-10-15 | Medtronic, Inc. | Implantable capacitive absolute pressure and temperature sensor |
US6132384A (en) * | 1996-06-26 | 2000-10-17 | Medtronic, Inc. | Sensor, method of sensor implant and system for treatment of respiratory disorders |
US6026326A (en) | 1997-01-13 | 2000-02-15 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
US6135945A (en) | 1997-08-04 | 2000-10-24 | Sultan; Hashem | Anti-incontinence device |
US6321116B1 (en) | 1998-02-08 | 2001-11-20 | Seung Kee Mo | Electrical apparatus medical treatment using EMG envelope signal |
US6002964A (en) | 1998-07-15 | 1999-12-14 | Feler; Claudio A. | Epidural nerve root stimulation |
US6221024B1 (en) | 1998-07-20 | 2001-04-24 | Medtronic, Inc. | Implantable pressure sensor and method of fabrication |
US6240316B1 (en) | 1998-08-14 | 2001-05-29 | Advanced Bionics Corporation | Implantable microstimulation system for treatment of sleep apnea |
US6652449B1 (en) | 1998-10-06 | 2003-11-25 | Bio Control Medical, Ltd. | Control of urge incontinence |
IL127481A (en) | 1998-10-06 | 2004-05-12 | Bio Control Medical Ltd | Incontinence treatment device |
US6585660B2 (en) * | 2001-05-18 | 2003-07-01 | Jomed Inc. | Signal conditioning device for interfacing intravascular sensors having varying operational characteristics to a physiology monitor |
-
2002
- 2002-02-15 US US10/076,869 patent/US6712772B2/en not_active Expired - Lifetime
-
2004
- 2004-01-20 US US10/761,005 patent/US20040152999A1/en not_active Abandoned
Patent Citations (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2816997A (en) * | 1955-02-23 | 1957-12-17 | Waters Corp | Resistance thermometer |
US3662758A (en) * | 1969-06-30 | 1972-05-16 | Mentor Corp | Stimulator apparatus for muscular organs with external transmitter and implantable receiver |
US3831588A (en) * | 1972-10-16 | 1974-08-27 | Device Res Inc | Pressure sensing device |
US4407296A (en) * | 1980-09-12 | 1983-10-04 | Medtronic, Inc. | Integral hermetic impantable pressure transducer |
US4730389A (en) * | 1986-08-15 | 1988-03-15 | Medtronic, Inc. | Method for fabrication of an implantable hermetic transparent container |
US5184619A (en) * | 1986-11-10 | 1993-02-09 | Peritronics Medical, Inc. | Intrauterine pressure and fetal heart rate sensor |
US4873986A (en) * | 1987-04-01 | 1989-10-17 | Utah Medical Products | Disposable apparatus for monitoring intrauterine pressure and fetal heart rate |
US4825876A (en) * | 1988-02-23 | 1989-05-02 | Abbott Laboratories | Encapsulated blood pressure transducer |
US5094242A (en) * | 1988-11-07 | 1992-03-10 | Regents Of The University Of California | Implantable nerve stimulation device |
US5211175A (en) * | 1988-11-07 | 1993-05-18 | Regents Of The University Of California | Method for implanting electra-acupuncture needle |
US5037488A (en) * | 1989-07-15 | 1991-08-06 | Heraeus Sensor Gmbh | Temperature sensor construction |
US5103835A (en) * | 1990-05-02 | 1992-04-14 | Nihon Kohden Corporation | Impedance monitoring device for preventing urinary incontinence |
US5969591A (en) * | 1991-03-28 | 1999-10-19 | The Foxboro Company | Single-sided differential pressure sensor |
US5324326A (en) * | 1991-11-25 | 1994-06-28 | Telectronics Pacing Systems, Inc. | Pressure sensing pacing lead |
US5411548A (en) * | 1993-01-11 | 1995-05-02 | Carman; Brent | Method of varying appropriate muscle strength of a person to alleviate urinary or fecal urgency or incontinence or vaginal or bladder spasms |
US5508476A (en) * | 1993-04-01 | 1996-04-16 | Plessey Semiconductors Limited | Mounting arrangement for semiconductor devices |
US5411538A (en) * | 1993-11-01 | 1995-05-02 | Intermedics, Inc. | Implantable medical device with detachable battery or electronic circuit |
US5522266A (en) * | 1993-11-30 | 1996-06-04 | Medex, Inc. | Low cost pressure transducer particularly for medical applications |
US5658321A (en) * | 1995-06-09 | 1997-08-19 | Ventritex, Inc. | Conductive housing for implantable cardiac device |
US5566680A (en) * | 1995-09-22 | 1996-10-22 | Graphic Controls Corporation | Transducer-tipped intrauterine pressure catheter system |
US5836886A (en) * | 1995-11-01 | 1998-11-17 | Kabushiki Kaisha Tokai Rika Denki Seisakusho | Catheter having a sensor |
US5807265A (en) * | 1996-01-09 | 1998-09-15 | Kabushiki Kaisha Tokai Rika Denki Seisakusho | Catheter having pressure detecting ability |
US5726624A (en) * | 1996-07-01 | 1998-03-10 | Honeywell Inc. | Temperature sensor with internal rigid substrate |
US5851226A (en) * | 1996-10-22 | 1998-12-22 | Medtronic, Inc. | Temporary transvenous endocardial lead |
US6019729A (en) * | 1996-11-15 | 2000-02-01 | Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho | Sensor mechanism-equipped catheter |
US6248083B1 (en) * | 1997-03-25 | 2001-06-19 | Radi Medical Systems Ab | Device for pressure measurements |
US6006135A (en) * | 1997-09-26 | 1999-12-21 | Medtronic, Inc. | Apparatus for interconnecting implantable electrical leads and medical device |
US6129658A (en) * | 1997-12-10 | 2000-10-10 | Varian Associates, Inc. | Method and apparatus creating a radioactive layer on a receiving substrate for in vivo implantation |
US6128531A (en) * | 1998-04-01 | 2000-10-03 | Pacesetter, Inc. | Delivery of ICD shock capacitor energy via a controlled current source |
US5984711A (en) * | 1998-09-10 | 1999-11-16 | Scimed Life Systems, Inc. | Methods and apparatus for increasing wire diameter to improve connectability |
US20020055764A1 (en) * | 1998-11-05 | 2002-05-09 | Dov Malonek | Multi-electrode lead |
US6253108B1 (en) * | 1999-04-30 | 2001-06-26 | Intermedics Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US6263241B1 (en) * | 1999-04-30 | 2001-07-17 | Intermedics, Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US6259949B1 (en) * | 1999-04-30 | 2001-07-10 | Intermedics, Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US6764472B1 (en) * | 2000-01-11 | 2004-07-20 | Bard Access Systems, Inc. | Implantable refillable infusion device |
US6915162B2 (en) * | 2000-11-16 | 2005-07-05 | St. Jude Medical Ab | Implantable medical device for measuring ventricular pressure |
US6477414B1 (en) * | 2001-04-26 | 2002-11-05 | Pacesetter, Inc. | Transformer assembly for implantable cardiac stimulation device |
US6712772B2 (en) * | 2001-11-29 | 2004-03-30 | Biocontrol Medical Ltd. | Low power consumption implantable pressure sensor |
US6862480B2 (en) * | 2001-11-29 | 2005-03-01 | Biocontrol Medical Ltd. | Pelvic disorder treatment device |
US7328068B2 (en) * | 2003-03-31 | 2008-02-05 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith |
US20060200200A1 (en) * | 2005-03-04 | 2006-09-07 | Malinowski Zdzislaw B | Hermetic implantable stimulator |
Cited By (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7948148B2 (en) | 1997-12-30 | 2011-05-24 | Remon Medical Technologies Ltd. | Piezoelectric transducer |
US7890176B2 (en) | 1998-07-06 | 2011-02-15 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating chronic pelvic pain |
US8934972B2 (en) | 2000-10-16 | 2015-01-13 | Remon Medical Technologies, Ltd. | Acoustically powered implantable stimulating device |
US8577460B2 (en) | 2000-10-16 | 2013-11-05 | Remon Medical Technologies, Ltd | Acoustically powered implantable stimulating device |
USRE42378E1 (en) | 2000-10-16 | 2011-05-17 | Remon Medical Technologies, Ltd. | Implantable pressure sensors and methods for making and using them |
US7930031B2 (en) | 2000-10-16 | 2011-04-19 | Remon Medical Technologies, Ltd. | Acoustically powered implantable stimulating device |
US7756587B2 (en) | 2000-10-16 | 2010-07-13 | Cardiac Pacemakers, Inc. | Systems and methods for communicating with implantable devices |
US8540631B2 (en) | 2003-04-14 | 2013-09-24 | Remon Medical Technologies, Ltd. | Apparatus and methods using acoustic telemetry for intrabody communications |
US20070142728A1 (en) * | 2003-04-14 | 2007-06-21 | Avi Penner | Apparatus and methods using acoustic telemetry for intrabody communications |
US9131902B2 (en) | 2004-02-05 | 2015-09-15 | Earlysense Ltd. | Prediction and monitoring of clinical episodes |
US8731646B2 (en) | 2004-02-05 | 2014-05-20 | Earlysense Ltd. | Prediction and monitoring of clinical episodes |
US8992434B2 (en) | 2004-02-05 | 2015-03-31 | Earlysense Ltd. | Prediction and monitoring of clinical episodes |
US8271093B2 (en) | 2004-09-17 | 2012-09-18 | Cardiac Pacemakers, Inc. | Systems and methods for deriving relative physiologic measurements using a backend computing system |
US8852099B2 (en) | 2004-09-17 | 2014-10-07 | Cardiac Pacemakers, Inc. | Systems and methods for deriving relative physiologic measurements |
US7813808B1 (en) | 2004-11-24 | 2010-10-12 | Remon Medical Technologies Ltd | Implanted sensor system with optimized operational and sensing parameters |
US20060247725A1 (en) * | 2005-04-28 | 2006-11-02 | Medtronic, Inc. | Multi-tube sensor for sensing urinary sphincter and urethral pressure |
US20060247723A1 (en) * | 2005-04-28 | 2006-11-02 | Medtronic, Inc. | Flexible tube sensor for sensing urinary sphincter pressure |
US7610093B2 (en) | 2005-04-28 | 2009-10-27 | Medtronic, Inc. | Implantable optical pressure sensor for sensing urinary sphincter pressure |
US20100030297A1 (en) * | 2005-04-28 | 2010-02-04 | Medtronic, Inc. | Implantable optical pressure sensor for sensing urinary sphincter pressure |
US7328070B2 (en) * | 2005-04-28 | 2008-02-05 | Medtronic, Inc. | Multi-tube sensor for sensing urinary sphincter and urethral pressure |
US7933653B2 (en) | 2005-04-28 | 2011-04-26 | Medtronic, Inc. | Implantable optical pressure sensor for sensing urinary sphincter pressure |
US20060247724A1 (en) * | 2005-04-28 | 2006-11-02 | Medtronic, Inc. | Implantable optical pressure sensor for sensing urinary sphincter pressure |
US7623923B2 (en) | 2005-04-28 | 2009-11-24 | Medtronic, Inc. | Tube sensor for penile tumescence |
US20060247682A1 (en) * | 2005-04-28 | 2006-11-02 | Medtronic, Inc. | Tube sensor for penile tumescence |
US8068910B2 (en) | 2005-04-28 | 2011-11-29 | Medtronic, Inc. | Flexible tube sensor for sensing urinary sphincter pressure |
US8478411B2 (en) | 2005-04-28 | 2013-07-02 | Medtronic, Inc. | Flexible tube sensor for sensing urinary sphincter pressure |
US7949394B2 (en) | 2005-09-09 | 2011-05-24 | Cardiac Pacemakers, Inc. | Using implanted sensors for feedback control of implanted medical devices |
US7742815B2 (en) | 2005-09-09 | 2010-06-22 | Cardiac Pacemakers, Inc. | Using implanted sensors for feedback control of implanted medical devices |
US20070142727A1 (en) * | 2005-12-15 | 2007-06-21 | Cardiac Pacemakers, Inc. | System and method for analyzing cardiovascular pressure measurements made within a human body |
US8078278B2 (en) | 2006-01-10 | 2011-12-13 | Remon Medical Technologies Ltd. | Body attachable unit in wireless communication with implantable devices |
US7650185B2 (en) | 2006-04-25 | 2010-01-19 | Cardiac Pacemakers, Inc. | System and method for walking an implantable medical device from a sleep state |
US20070252713A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | External voiding sensor system |
US20070255176A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Voiding detection with learning mode |
US7855653B2 (en) | 2006-04-28 | 2010-12-21 | Medtronic, Inc. | External voiding sensor system |
US8072338B2 (en) | 2006-04-28 | 2011-12-06 | Medtronic, Inc. | External voiding sensor system |
US20090174559A1 (en) * | 2006-04-28 | 2009-07-09 | Medtronic, Inc. | External voiding sensor system |
US7522061B2 (en) | 2006-04-28 | 2009-04-21 | Medtronic, Inc. | External voiding sensor system |
US7908334B2 (en) | 2006-07-21 | 2011-03-15 | Cardiac Pacemakers, Inc. | System and method for addressing implantable devices |
US7955268B2 (en) | 2006-07-21 | 2011-06-07 | Cardiac Pacemakers, Inc. | Multiple sensor deployment |
US20080021972A1 (en) * | 2006-07-21 | 2008-01-24 | Cardiac Pacemakers, Inc. | System and method for addressing implantable devices |
US8340776B2 (en) | 2007-03-26 | 2012-12-25 | Cardiac Pacemakers, Inc. | Biased acoustic switch for implantable medical device |
US8821418B2 (en) | 2007-05-02 | 2014-09-02 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US8734360B2 (en) | 2007-05-02 | 2014-05-27 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US20090021226A1 (en) * | 2007-07-19 | 2009-01-22 | Mitsutoshi Fujita | Semiconductor integrated circuit and sensor driving/measuring system |
US8085012B2 (en) | 2007-07-19 | 2011-12-27 | Panasonic Corporation | Semiconductor integrated circuit and sensor driving/measuring system |
US20090177251A1 (en) * | 2008-01-07 | 2009-07-09 | Paul Huelskamp | System And Method For In Situ Trimming Of Oscillators In A Pair Of Implantable Medical Devices |
US8041431B2 (en) | 2008-01-07 | 2011-10-18 | Cardiac Pacemakers, Inc. | System and method for in situ trimming of oscillators in a pair of implantable medical devices |
US20090198307A1 (en) * | 2008-02-06 | 2009-08-06 | Bin Mi | Direct inductive/acoustic converter for implantable medical device |
US8301262B2 (en) | 2008-02-06 | 2012-10-30 | Cardiac Pacemakers, Inc. | Direct inductive/acoustic converter for implantable medical device |
US8725260B2 (en) | 2008-02-11 | 2014-05-13 | Cardiac Pacemakers, Inc | Methods of monitoring hemodynamic status for rhythm discrimination within the heart |
US8369960B2 (en) | 2008-02-12 | 2013-02-05 | Cardiac Pacemakers, Inc. | Systems and methods for controlling wireless signal transfers between ultrasound-enabled medical devices |
US9883809B2 (en) | 2008-05-01 | 2018-02-06 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US8998830B2 (en) | 2008-05-12 | 2015-04-07 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US8882684B2 (en) | 2008-05-12 | 2014-11-11 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
US8798761B2 (en) | 2008-06-27 | 2014-08-05 | Cardiac Pacemakers, Inc. | Systems and methods of monitoring the acoustic coupling of medical devices |
US8594802B2 (en) | 2008-08-14 | 2013-11-26 | Cardiac Pacemakers, Inc. | Performance assessment and adaptation of an acoustic communication link |
US20100042177A1 (en) * | 2008-08-14 | 2010-02-18 | Cardiac Pacemakers, Inc. | Performance assessment and adaptation of an acoustic communication link |
US8126566B2 (en) | 2008-08-14 | 2012-02-28 | Cardiac Pacemakers, Inc. | Performance assessment and adaptation of an acoustic communication link |
US8401662B2 (en) | 2008-08-14 | 2013-03-19 | Cardiac Pacemakers, Inc. | Performance assessment and adaptation of an acoustic communication link |
US8591423B2 (en) | 2008-10-10 | 2013-11-26 | Cardiac Pacemakers, Inc. | Systems and methods for determining cardiac output using pulmonary artery pressure measurements |
US8593107B2 (en) | 2008-10-27 | 2013-11-26 | Cardiac Pacemakers, Inc. | Methods and systems for recharging an implanted device by delivering a section of a charging device adjacent the implanted device within a body |
US9024582B2 (en) | 2008-10-27 | 2015-05-05 | Cardiac Pacemakers, Inc. | Methods and systems for recharging an implanted device by delivering a section of a charging device adjacent the implanted device within a body |
US8632470B2 (en) | 2008-11-19 | 2014-01-21 | Cardiac Pacemakers, Inc. | Assessment of pulmonary vascular resistance via pulmonary artery pressure |
US20100244813A1 (en) * | 2009-03-30 | 2010-09-30 | Pcb Piezotronics, Inc. | Bridge sensor with collocated electronics and two-wire interface |
US8179121B2 (en) | 2009-03-30 | 2012-05-15 | Pcb Piezotronics, Inc. | Bridge sensor with collocated electronics and two-wire interface |
US20110066046A1 (en) * | 2009-09-16 | 2011-03-17 | Young Darrin J | Implantable flat blood pressure sensing cuff structure and implantable blood pressure monitoring device using the cuff structure |
US8602999B2 (en) * | 2009-09-16 | 2013-12-10 | Darrin J. Young | Implantable flat blood pressure sensing cuff structure and implantable blood pressure monitoring device using the cuff structure |
US8380312B2 (en) | 2009-12-31 | 2013-02-19 | Ams Research Corporation | Multi-zone stimulation implant system and method |
US9457186B2 (en) | 2010-11-15 | 2016-10-04 | Bluewind Medical Ltd. | Bilateral feedback |
US10292625B2 (en) | 2010-12-07 | 2019-05-21 | Earlysense Ltd. | Monitoring a sleeping subject |
US11147476B2 (en) | 2010-12-07 | 2021-10-19 | Hill-Rom Services, Inc. | Monitoring a sleeping subject |
US9731112B2 (en) | 2011-09-08 | 2017-08-15 | Paul J. Gindele | Implantable electrode assembly |
US10602936B2 (en) | 2015-04-06 | 2020-03-31 | Thomas Jefferson University | Implantable vital sign sensor |
US10335043B2 (en) | 2015-04-06 | 2019-07-02 | Thomas Jefferson University | Implantable vital sign sensor |
US10413200B2 (en) | 2015-04-06 | 2019-09-17 | Thomas Jefferson University | Implantable vital sign sensor |
US11000195B2 (en) | 2015-04-06 | 2021-05-11 | Thomas Jefferson University | Implantable vital sign sensor |
US9629560B2 (en) | 2015-04-06 | 2017-04-25 | Thomas Jefferson University | Implantable vital sign sensor |
US11330987B2 (en) | 2015-04-06 | 2022-05-17 | Thomas Jefferson University | Implantable vital sign sensor |
US11445924B2 (en) | 2015-04-06 | 2022-09-20 | Thomas Jefferson University | Implantable vital sign sensor |
CN107348959A (en) * | 2016-05-09 | 2017-11-17 | 上银科技股份有限公司 | Physiological signal sensing device and its operation method of start and shutdown |
Also Published As
Publication number | Publication date |
---|---|
US6712772B2 (en) | 2004-03-30 |
US20030100839A1 (en) | 2003-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6712772B2 (en) | Low power consumption implantable pressure sensor | |
EP1578247B1 (en) | Low power consumption implantable pressure sensor | |
US7418872B2 (en) | System and apparatus for sensing pressure in living organisms and inanimate objects | |
EP0178528B1 (en) | Method for adjusting heart/pacer rate relative to right ventricular systolic pressure to obtain a required cardiac output | |
US7976534B2 (en) | Event triggered infection monitoring | |
US4485813A (en) | Implantable dynamic pressure transducer system | |
US5040533A (en) | Implantable cardiovascular treatment device container for sensing a physiological parameter | |
US8744544B2 (en) | System having wireless implantable sensor | |
US8543205B2 (en) | Temperature sensor for a leadless cardiac pacemaker | |
US4708143A (en) | Method for controlling pacing of a heart in response to changes in stroke volume | |
JP2786943B2 (en) | Implantable capacitive absolute pressure and temperature monitoring system | |
US7682355B2 (en) | Refined infection monitoring | |
US4802481A (en) | Apparatus for controlling pacing of a heart in response to changes in stroke volume | |
US7611483B2 (en) | Indicator metrics for infection monitoring | |
EP1981588B1 (en) | Implantable cardiac stimulator, device and system for monitoring the status of a cardiac lead | |
US4827933A (en) | Apparatus and method for adjusting heart/pacer rate relative to cardiac pO2 obtain a required cardiac output | |
US7766862B2 (en) | Baseline acquisition for infection monitoring | |
US20080262331A1 (en) | Infection monitoring | |
US8209031B1 (en) | Implantable lead for measuring physiologic information | |
Meindl | Biomedical implantable microelectronics | |
EP3788948A1 (en) | Implantable electronic sensing system for measuring and monitoring medical parameters | |
CN116943030A (en) | Device based on ultrasonic signal and implantable medical equipment | |
EP2142092A1 (en) | Indicator metrics for infection monitoring |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BIOCONTROL MEDICAL LTD., ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BETSER, NIR;REEL/FRAME:019959/0822 Effective date: 20070711 |
|
AS | Assignment |
Owner name: AMERICAN MEDICAL SYSTEMS, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOCONTROL MEDICAL LTD.;REEL/FRAME:020618/0610 Effective date: 20080228 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: MEDTRONIC, INC.,MINNESOTA Free format text: SECURITY AGREEMENT;ASSIGNOR:BIO CONTROL MEDICAL (B.C.M.) LTD;REEL/FRAME:024411/0365 Effective date: 20100506 Owner name: MEDTRONIC, INC., MINNESOTA Free format text: SECURITY AGREEMENT;ASSIGNOR:BIO CONTROL MEDICAL (B.C.M.) LTD;REEL/FRAME:024411/0365 Effective date: 20100506 |
|
AS | Assignment |
Owner name: MEDTRONIC, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOCONTROL ,EDICAL (B.C.M.) LTD;REEL/FRAME:046574/0208 Effective date: 20180628 |